Mast cell quantification and substance P immunoreactivity during the acute and chronic stages of pneumonic pasteurellosis in ruminants by Ramirez-Romero, Rafael
Retrospective Theses and Dissertations Iowa State University Capstones, Theses andDissertations
2000
Mast cell quantification and substance P
immunoreactivity during the acute and chronic
stages of pneumonic pasteurellosis in ruminants
Rafael Ramirez-Romero
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/rtd
Part of the Veterinary Pathology and Pathobiology Commons
This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University
Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University
Digital Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Ramirez-Romero, Rafael, "Mast cell quantification and substance P immunoreactivity during the acute and chronic stages of
pneumonic pasteurellosis in ruminants " (2000). Retrospective Theses and Dissertations. 13925.
https://lib.dr.iastate.edu/rtd/13925
INFORMATION TO USERS 
This manuscript has been reproduced from the microfilm master. UMI films the 
text directly from the original or copy sutmiitted. Thus, some thesis and 
dissertation copies are in typewriter face, while others may t>e from any type of 
computer printer. 
The quality of this reproduction is dependent upon the quality of the copy 
submitted. Broicen or indistinct print, colored or poor quality illustrations and 
photographs, print bleedthrough, substandard margins, and improper alignment 
can adversely affect reproduction. 
In the unlikely event that the author did not send UMI a complete manuscript and 
there are missing pages, these will be noted. Also, if unauthorized copyright 
material had to be removed, a note will indicate the deletion. 
Oversize materials (e.g., maps, drawings, charts) are reproduced by sectioning 
the original, beginning at the upper left-hand comer and continuing from left to 
right in equal sections with small overiaps. 
Photographs included in the original manuscript have been reproduced 
xerographically in this copy. Higher quality 6' x 9' black and white photographic 
prints are available for any photographs or illustrations appearing in this copy for 
an additional charge. Contact UMI directly to order. 
Bell & Howell Informatton and Learning 
300 North Zeeb Road, Ann Arbor. Ml 48106-1346 USA 
UMI* 
800-521-0600 

Mast cell quantification and substance P immunoreactivity during the acute and 
chronic stages of pneumonic pasteurellosis in ruminants 
by 
Rafael Ramirez-Romero 
A dissertation submitted to the graduate faculty 
in partial fulfillment of the requirements for the degree of 
DOCTOR OF PHILOSOPHY 
Major: Veterinary Pathology 
Major Professor Mark R. Ackermann 
Iowa State University 
Ames, Iowa 
2000 
UMI Number; 9962841 
UMI 
UMI Microfomi9962841 
Copyright 2000 by Bell & Howell Infomiation and teaming Company. 
All rights reserved. This microform edition is protected against 
unauthorized copying under Title 17, United States Code. 
Bell & Howell Information and Leaming Company 
300 North Zeeb Road 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346 
ii 
Graduate College 
Iowa State University 
This is to certify that the Doctoral dissertation of 
Rafael Ramirez-Romero 
has met the dissertation requirements of Iowa State University 
Major Professor 
For the Major Program 
Graduate College 
Signature was redacted for privacy.
Signature was redacted for privacy.
Signature was redacted for privacy.
iii 
To my Wife 
Maria Dolores 
And my Daughter 
Cecilia 
In memory of my Brother 
Manuel 
iv 
TABLE OF CONTENTS 
ABSTRACT vii 
CHAPTER 1. GENERAL INTRODUCTION 1 
Introduction 1 
Dissertation Organization 2 
References 2 
CHAPTER 2. LITERATURE REVIEW 4 
Mast Cells 4 
Tachykinins 12 
References 23 
CHAPTER 3. REDUCTION OF PULMONARY MAST CELLS 
IN AREAS OF ACUTE INFLAMMATION IN CALVES WITH 
MANNHEIMIA (PASTEURELLA) HAEMOLYTICA PNEUMONIA 32 
Summary 32 
Introduction 32 
Materials and Methods 33 
Results 35 
Discussion 37 
Acknowledgments 39 
References 39 
CHAPTER 4. DIHYDROCAPSAICIN TREATMENT DEPLETES 
PEPTIDERGIC NERVE FIBERS OF SUBSTANCE P AND ALTERS 
MAST CELL DENSITY IN THE RESPIRATORY TRACT OF 
NEONATAL SHEEP 47 
Abstract 47 
Introduction 47 
Material and Methods 49 
Results 53 
Discussion 55 
Acknowledgments 58 
References 58 
CHAPTER 5. MAST CELL DENSITY AND SUBSTANCE P-LIKE 
IMMUNOREACTIVITY DURING THE INITIATION AND 
PROGRESSION OF LUNG LESIONS IN OVINE MANNHEIMIA 
(PASTEURELLA) HAEMOLYTICA PNEUMONIA 73 
Abstract 73 
V 
Materials and Methods 75 
Results 78 
Discussion 84 
Acknowledgments 90 
References 90 
CHAPTER 6. GENERAL CONCLUSIONS 105 
vi 
ACKNOWLEDGEMENTS 
The author is grateful to Universidad Autonoma de Nuevo Leon and CONACYT, Mexico. 
vii 
ABSTRACT 
The objective of this work was to determine the numbers of stained mast cells (MCs) 
and substance P (SP) immunoreactivity during the initiation and progression of 
pulmonary lesions in a model of pneumonic pasteurellosis (PP) in ruminants. The first 
experiment demonstrated that, at 6 h after intrabronchial deposition of Mannheimia 
{Pasteurella) haemolytica in neonatal calves, MC numbers decreased in sites of severe 
lung damage. Prior administration of a sialyl Lewis mimetic (TBC1269) intended to 
prevent neutrophil infiltration had no effect on MC numbers, suggesting that MC 
degranulation is unaffected by selectin inhibition. In the second study, a single high dose 
of dihydrocapsaicin (DHC) administered to neonatal iambs depleted peptidergic nerves 
of SP. Depletion was measured in nasal septum, the site richest in SP fibers, and was 
estimated to be 85% of controls. In the upper and lower respiratory tract MC density 
increased progressively with age, from 3 to 21 days, but DHC-treated animals had 
significantly higher numbers of MCs; this suggests a functional association between 
MCs and SP fibers. Histamine content in the lung was similar to controls. The model is 
suitable for studies of the inflammatory response in the respiratory tract when the 
neurogenic contribution is reduced. In the third experiment, diminished numbers of MCs 
and histamine during the acute phase (1 day) of PP in sheep were associated with SP 
immunoreactivity in macrophages infiltrating the areas of severe damage, suggesting an 
extraneural source of SP. At 15 days, MCs were scarce at sites with pyogranulomatous 
foci, but increased in areas with interstitial pneumonia. Substance P immunoreactivity 
demonstrated that not only an extrinsic sensory innervation, but also an intrinsic 
contribution of pulmonary ganglion neurons, sustain the inflammatory response. At 45 
days the fibroplastic changes in pleura, interlobular spaces, and interstitium were 
marked, as was the presence of bronchiolitis obliterans. These changes were associated 
with an increased number of MCs; however, the elevation in histamine did not 
correspond with the MCs increment. In areas of severe fibrosis SP immunoreactivity in 
nerve fibers was mild suggesting that the absence of SP during chronic PP hinders 
tissue repair. 
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CHAPTER 1. GENERAL INTRODUCTION 
Introduction 
Pasteurella haemolytica is commonly isolated from natural cases of fibrinous 
pleuropneumonia in cattle, which is the most characteristic lesion of pneumonic 
pasteurellosis (PP) (Whiteley etal., 1992; Ramirez-Romero and Brogden, 1995). This 
pneumonic syndrome has been rated the most economically important disease in the 
cattle industry in North America (De Alwis, 1993). The economic impact of PP Is 
attributed to mortality, morbidity, and reduced productivity (Martin et a!., 1981). 
P. haemolytica has been renamed Mannheimia haemolytica (Angen etal., 1999). 
The bacterium posses several virulence factors; however, the most important are 
leukotoxin (LKT) and lipopolysaccharide (LPS) (Ramirez-Romero and Brogden, 1995). 
Leukotoxin and LPS have the capability to induce tissue damage in the lung of 
ruminants (Whiteley etal., 1992). However, experimental studies in ruminants and 
laboratory animals have demonstrated that the LPS contributes more than LKT to the 
inflammatory process (Dungworth, 1993; Ramirez-Romero and Brogden, in press). 
The pathogenesis of PP remains incompletely understood. Although the bacteria 
and their virulence factors are potent inducers of inflammation, there is evidence that the 
host inflammatory response is excessive and contributes to the pathogenesis of the 
severe lung damage (Ramirez-Romero and Brogden, in press). Recently, it has been 
proposed that two classical models of acute inflammatory response, the Arthus and 
Shwartzman reactions, may explain the pathogenesis of the characteristic lesions in PP 
(Ramfrez-Romero and Brogden, in press). Nonetheless, the pathogenic mechanisms 
operating during the progression of the pulmonary lesions have not been fully defined. 
Few studies have assessed the role of mast cells (MCs) in PP. Adusu et al. 
(1994) reported that MCs recovered from cattle infected experimentally with M. 
haemolytica release increased amount of histamine in vitro, and M. haemolytica LKT 
and LPS both cause an increase in the spontaneous release of histamine from isolated 
bovine lung parenchyma (Saban etal., 1997). However, there have been no studies on 
the influence of the acute and chronic inflammatory response induced by M. haemolytica 
on the numbers of MCs in the lung. Similarly, the role of substance P (SP), a 
neuropeptide that induces MC activation during neurogenic inflammation in the lung 
(Baluk, 1997), has not been defined in PP. 
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The main objective of this work was to determine the numbers of stainable l\^Cs 
and SP immunoreactivity during the initiation and progression of the pulmonary lesions 
in a model of PP in ruminants. 
Dissertation Organization 
The dissertation is organized in an alternate format including six chapters composed of 
general introduction, a brief review of the literature, three papers suitable for publication, 
and general conclusions, respectively. The references have been presented at the end 
of each chapter. The manuscripts included correspond to three separate experiments. 
The first one has been accepted for publication in Journal of Comparative Pathology, the 
second has been submitted to Regulatory Peptides, and the third is prepared for 
submission to Veterinary Pathology. In all of them the first author is the Ph.D. Candidate 
Rafael Ramirez-Romero and Mark R. Ackermann, the Major Professor, is co-author. 
In the first experiment, the number of stainable MCs was determined during the 
acute phase of M. haemolytica pneumonia in calves: additionally, the role of a 
compound that acts by competition as selectin inhibitor was included to determine its 
influence on MCs in vivo. During the second experiment, the effect of dihydrocapsaicin 
in depleting peptidergic fibers of SP was determined in neonatal lambs. Subsequently, 
the influence of SP depletion on MC density in the respiratory tract was determined. This 
experiment was designed to provide an animal model suitable for the study of respiratory 
tract inflammation in which neurogenic inflammation was diminished. The third 
experiment was carried out to quantify the relative relationships between 
histopathological changes in lung parenchyma, MC numbers, and SP production, during 
the acute, sub-acute, and chronic stages of PP in sheep. The results obtained from the 
three experiments provide evidence that MCs and SP are important components of the 
lung inflammatory response during initiation and progression of PP. 
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CHAPTER 2. LITERATURE REVIEW 
Mast Cells 
Mast cells are bone marrow-derived cells, carried as immature cells in the bloodstream, 
that complete their final steps of maturation after an i^val in tissues (Metcalfe et ai, 1997; 
Welle, 1997). Mast cells acquire their phenotypic characteristics in specific 
microenviromental conditions of the tissues they colonize, and thus represent a widely 
heterogenous population (Metcalfe et a/., 1997; Welle, 1997). Traditionally described as 
the cells responsible for the severe effects of type I hypersensitivity, MCs are now 
recognized as orchestrators of the defense mechanisms, both acquired and innate (Galli 
eta!., 1999; Galli, 2000). Mast cells posses an array of adhesion molecules and 
immunoglobulin receptors that provide them with the capability to react to multiple 
specific and non-specific stimuli (Metcalfe et al., 1997). In addition, MCs phagocytose 
bacteria and present antigens to lymphocytes (Malaviya etal., 1996b; Abraham et al., 
1997; Mekori and Metcalfe, 1999), produce cytokines and release vasoactive 
compounds necessary to mount the inflammatory and immune responses (Metcalfe et 
al., 1997; Mekori and Metcalfe, 1999), and contain proteases and growth factors that act 
in remodeling tissues (Levi-Schaffer, 1995), among other functions. 
At 15 days of gestation there are three different populations of precursor cells in 
the blood of fetal mice that can be separated by their expression of Thy-1 and c-Kit. 
These populations are Thy-r c-Kit"^, Thy-r c-Kit'°, and Thy-1c-Kit"', and con^espond to 
multipotent hematopoietic stem cells, pro-thymocytes, and pro-mastocytes, respectively 
(Rodewald et al., 1996). This means that commitment to the MC lineage precedes tissue 
immigration and occurs earlier during hematopoiesis (Rodewald et al., 1996). In human 
beings MC precursors have the CD34* marker and express also c-Kit". Therefore, they 
are responsive to stem cell factor (SCF; also called mast cell growth factor. Steel factor, 
and c-Kit ligand) (Metcalfe etal., 1995; Broudy, 1997). 
Thy-1 is a glycoprotein belonging to the immunoglobulin superfamily whereas 
CD34" is a Ser/Thr-rich sialomucin, and both are commonly present in hematopoietic 
stem cells and influence their maturation. However, it is the presence of c-Kit, the 
receptor, and SCF, its ligand, that establish commitment and homing of the MC lineage 
(Metcalfe etal., 1995; Broudy, 1997). More recently it has been reported that eotaxin 
acts synergistically with SCF to promote the growth and differentiation of MC precursors 
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(Quackenbusch etal., 1998). Additionally, for optimal proliferation and differentiation, 
MCs require complementary factors such as interleukin (IL)-3, IL-4, IL-9, and IL-10, and 
nerve growth factor (NGF) (Metcalfe et al., 1995; Metcalfe et al., 1997). Conversely, 
granulocyte-macrophage colony-stimulating factor (GM-CSF) and transforming growth 
factor (TGF)-p inhibit MC differentiation (Metcalfe et al., 1995). 
The early MC precursors contain characteristic cytoplasmic granules and 
express RNAs encoding mast cell-proteases but lack the high-affinity IgE receptor 
(FCERI) (Rodewald et al., 1996). The synthesis of the proteoglycan matrix, particularly 
heparin, is a pre-requisite to complete the adequate synthesis of granule components 
because improper sulfation of the matrix impedes the expression of proteases and 
probably other components (Humphries etal., 1999; Forsberg ef a/., 1999). Apparently, 
FCERI is a marker of terminal differentiation (Metcalfe et al., 1995). 
lnterleukin-3 is an important factor for MCs from murine and human origin, and 
can sustain, alone, the growth of MCs in vitro (Metcalfe et al., 1995; Metcalfe et al., 
1997). It has been reported that withdrawal of IL-3 induces MC apoptosis but addition of 
SCF can prevent it (Metcalfe et al., 1995). The "rescue" effect of SCF is not fully 
understood but apparently is not mediated by bcl-2 (Metcalfe et al., 1995; Metcalfe et al., 
1997). Conversely TGF-p inhibits the "rescue" effect of SCF when MCs are deprived of 
IL-S; the mechanism is probably related to the down-regulation of c-Kit expression 
induced by TGF-p (Metcalfe et al., 1995; Metcalfe et al., 1997). On the other hand, 
murine MCs express the Fas antigen and are susceptible to Fas-mediated apoptosis 
(Hartmann et al., 1997). More recently, it was reported that MCs also express the Fas 
ligand but cannot induce apoptosis in Fas-bearing cells because their Fas ligand is 
localized intracellulariy (Wagelie-Steffen etal., 1998). An autocrine pathway of Fas-
mediated apoptosis may regulate MC populations and specific stimuli may be required 
for surface expression of Fas ligand (Wagelie-Steffen et al., 1998). 
Stem cell factor is normally produced in soluble and transmembrane forms and 
both fomns are biologically active (Broudy, 1997). Stem cell factor is constitutively 
produced by endothelial cells and fibroblasts which display the transmembrane fonn and 
also release soluble SCF (Broudy, 1997). Additionally, SCF is also produced by 
keratinocytes and intestinal epithelial cells (Broudy, 1997), as well as MCs (de Paulis et 
al., 1999). Human lung MCs store SCF in their granules and after being released, the 
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protease chymase cleaves SCF giving a shorter protein that is still biologically active and 
thereby, may exert autocrine and paracrine actions (de Paulis et a!., 1999). 
The c-kA proto-oncogene encodes a growth factor receptor (c-Kit), with ligand-
dependent tyrosine kinase activity and immunoglobulin (IgHike domains (Ig superfamily 
member), stmcturally related to the platelet-derived growth factor (PDGF) receptor 
(Timokhina et al., 1998). After being activated by the corresponding ligand (SCF), c-KIt 
dimerizes to permit its autophosphorylation and becomes able to bind and activate 
several molecules. c-Kit activation causes phosphorylation and activation of both an 
adaptor protein (She) and an exchange GDP/GTP (Vav) factor that allow incorporation 
and activation of Ras monomeric GTPases (Rac) (Timokhina et al., 1998). In addition, 
activated c-Kit pennits association with phosphatidylinositol 3'-kinase (PI 3-kinase), 
phospholipase Cy-1, an adaptor protein (Grb2), tyrosine phosphatases (SHP1 and 
SHP2), and Src kinases (Fyn, Lyn) (Timokhina et al., 1998). It has been demonstrated 
that after ligand-mediated c-Kit activation, the PI 3-kinase and Fyn pathways converge 
downstream to activate Rac1 and subsequently (RAF->MEK-»MAPK), the protein 
kinase c-jun-N-terminal kinase (JNK); these signaling pathways are required during MC 
sun/ival and proliferation (Timokhina et al., 1998). 
Genetically MC-deficient mice have been very useful in understanding the role of 
c-Kit and SCF in MC maturation. The c-kit proto-oncogene is located at the W (white 
spotting) locus and mutations have relevant effects not only in hematopoiesis but also in 
gametogenesis and melanogenesis (Metcalfe et al., 1995; Metcalfe et al., 1997). The 
mutant mice W/W suffer from hypoplastic anemia, hypopigmentation, and sterility, apart 
from lacking MCs (Castells, 1997). This is because hematopoietic cell precursors, gemn 
cells, and melanocytes, all are derived from the neural crest and employ the same 
mechanism of cell growth and regulation. When W/W mice receive a bone marow 
transplant from normal mice {+/•*•) the deficiency in MCs is restored indicating that the 
deficiency resides in the MC precursors themselves (Metcalfe et al., 1995; Castells, 
1997; Metcalfe etai, 1997). Conversely, mutant mice, which show abnormalities 
similar to I/V5W mice, cannot be restored from MC deficiency by +/+ bone marrow 
transplant; however, bone marrow from Sl/Sf can restore MC deficiency In I/I//W mice, 
which implies, in this case, a deficiency in tissue microenviromental factors that regulate 
MC maturation (Metcalfe et al., 1995; Castells, 1997; Metcalfe et al., 1997). This is 
because a gene located at the SI (Steel) locus encodes SCF. Although Sl/Sf mice have 
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a soluble form of SCF, the deficiencies in hematopoiesis (including lack of MCs), 
gametogenesis, and pigmentation, suggest that the transmembrane fomri of SCF is 
required for proper cellular growth and maturation (Broudy, 1997). 
Considering their location and also their morphological and histochemical 
characteristics, mast cells are broadly assigned to one of two categories, mucosal mast 
cells (MMC) or connective tissue mast cells (CTMC) (Abraham etal., 1997; Metcalfe et 
al., 1997; Welle, 1997). Mucosal mast cells are primarily found in close proximity to the 
epithelium in the respiratory, urogenital and intestinal mucosa. Conversely, CTMC are 
found in the skin, peritoneal cavity, the muscular layer of the intestine and around 
venules in the lung. This classification was based in original studies in mice and rats and 
by analogy also has been employed in humans (Abraham et al., 1997; Metcalfe et al., 
1997). 
There are several differences in function between MMC and CTMC. For 
example, MMC contain chondroitin sulfate as the main matrix component and little 
histamine (<2 pg/ cell); these cells are sensitive to formaldehyde fixation and require 
special conditions for proper fixation and staining. Connective tissue mast cells contain 
heparin in their granules and large amounts of histamine (< 35 pg/ cell); these cells are 
fonnaldehyde resistant (Metcalfe etal., 1997; Welle, 1997). Mucosal mast cells are 
considered migratory cells with a short life span (half life < 40 days) whereas CTMC are 
tissue fixed cells that live longer (half life > 6 months) (Welle, 1997). In addition, the 
population of MMC expands remarkably during T cell-dependent immune responses 
whereas CTMC exhibit little or no T cell-dependence; CTMC occur in similar numbers in 
athymic nude and in euthymic mice (Metcalfe et al., 1997). Nonetheless, not all rat and 
mouse MCs obsen/ed in situ can be readily categorized and most of the tissues contain 
a mixed population including uncategorized MCs (Metcalfe etal., 1997). On the other 
hand, MMC can develop into CTMC and vice versa, depending on the 
microenviromental conditions in the tissue (Welle, 1997). It is generally accepted that 
murine MCs cultured in the presence of IL-3 become MMC whereas exposure to SCF or 
fibroblasts with or without IL-3 induces a CTMC phenotype (Welle, 1997). 
The most effective mariners for characterization of MC subpopulations are 
the proteases in their cytoplasmic granules. Neutral proteases (serine proteases) are 
quantitatively important and represent constituents restricted to MC granules (Metcalfe 
et al., 1997; Welle, 1997). Mast cell proteases have been classified as chymases or 
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tryptases because their chymotrypsin- and trypsin-like enzymatic activity (Welle, 1997). 
Moreover, tryptase and chymase are the main histochemical markers for recognition of 
MCs in tissue sections in humans (Metcalfe et aL, 1997). Based on these markers, MCs 
have been classified in MCtc for those cells that contain tryptase, chymase and other 
proteases (carboxypeptidase and cathepsin G-like protease), and MCt for those MCs 
that contain only tryptase (Metcalfe et aL, 1997; Welle, 1997). In humans, MCt 
predominate in the alveolar septa of the lung and in the small intestine mucosa; 
conversely, MCtc predominate in the skin and In the small Intestine submuccsa. 
Therefore, in terms of tissue localization, the human MCt correspond most closely to the 
rodent MMC whereas MCtc are much more related to rodent CTMC (Metcalfe et al., 
1997). Tryptases and chymases have been recognized in MCs from rodents (Welle, 
1997), cattle (Kuther efa/., 1998), dog (Kube etal., 1998), and horse (Welle etal., 
1997). In sheep and goat, however, the MC proteases have a unique dual function being 
either tryptase- or chymase-like, depending on the microenviromental conditions 
(Pemberton etal., 1997; Macaldowie et al., 1998). 
Mast cell proteases are stored in the proteglycan matrix of MC granules in an 
active state but effectively stabilized at pH 5.5 in the cells. This stabilization is due to a 
strong ionic binding of the positive charged proteases with the highly negative charged 
proteoglycans, mainly heparin and chondroitin sulfate (Welle, 1997; Walls, 1998). After 
degranulation, however, the proteases are released by catlonic exchange at neutral pH 
but probably exert their function only in close proximity to the site of release because 
subsequent attachment to extracellular matrix proteoglycans, such as heparan sulfate, is 
highly possible (Walls, 1998). It has been estimated that human lung MCs contain 11 pg/ 
cell of tryptase and 2.6 pg/ cell of chymase but skin MCs have higher amounts of these 
enzymes (Walls, 1998). 
In humans there are two types of MC tryptases, a-tryptase and p-tryptase. Alpha-
tryptase seems to be constitutively released and is nomfially found in the blood of healthy 
individuals but also in some pathological conditions such as mastocytosis. Conversely, 
p-tryptase is released during anaphylactic reactions (Walls, 1998). Tryptase promotes 
the inflammatory response because it degranulates neighboring MCs and is chemotactic 
for neutrophils and eosinophils (Walls, 1998). Also, tryptase can induce expression of IL-
8 and upregulation of intercellular adhesion molecule-1 (ICAM-1) on epithelial cells 
(Welle, 1997; Walls, 1998). Tryptase cleaves high molecular weight kininogen (HMWK) 
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and thereby generate kinins; tryptase also inactivates fibrinogen and thereby limits the 
clotting reaction. All these activities could potentiate the inflammatory reaction (Welle, 
1997; Walls, 1998). Moreover, tryptase degrades the neuropeptides vasoactive intestinal 
peptide (VIP) and calcitonin gene-related peptide (CGRP), probably as a regulatory 
mechanism during neurogenic inflammation (Walls, 1998). Tryptase is involved in tissue 
degradation and remodeling because it activates stromelysin and urokinase 
plasminogen activator, and cleaves fibronectin. In addition, tryptase acts as a growth 
factor for smooth muscle cells, fibroblasts, and epithelial cells, and induces collagen 
synthesis from fibroblasts (Welle, 1997; Walls, 1998). Finally, tryptase activates atrial 
natiuretic peptide (Walls, 1998). 
A new role for tryptase has been recently identified. Trypsin and tryptase can 
activate by proteolysis a specific G protein-coupled receptor that belongs to the 
proteinase-activated receptors (PARs), thus acting as signaling molecules (Dery etal., 
1998). There are three known members of this PARs family: PAR-1 and and PAR-3 are 
cleaved and activated by thrombin whereas PAR-2 is a receptor for trypsin-like enzymes 
(Dery et al., 1998). The mechanism of activation includes recognition of the G-protein-
coupled receptor by the enzyme, cleavage of the receptor at a specific enzymatic site 
within the NH2-extracellular terminus, and exposure of a new NHa-tenminus that acts as 
a tethered ligand that specifically binds and activates its own cleaved receptor (Dery et 
al., 1998). Evidence Indicates that PAR-2 is most likely coupled to heterotrimeric Gaq or 
Gao proteins (Dery etal., 1998). Proteinase-activated receptor-2 Is expressed in 
epithelial, endothelial, smooth muscle cells, and fibroblasts in several tissues, including 
the ain/vays (Akers et al., 2000), as well as in PMNs (Dery et al., 1998) and sensory 
nerves (Steinhoff et al., 2000). It is possible that the pro-inflammatory (including 
neurogenic inflammation) and mitogenic influences exerted by tryptase may be mediated 
by PAR-2 (Akers et al., 2000; Steinhoff et al., 2000). 
Chymase has been involved in tissue inflammation and remodeling. For instance, 
rat chymase cleaves type IV and type Vl collagens, fibronectin and vitronectin, and also 
activates stromelysin (Walls, 1998). Chymase, like tryptase, can cleave VIP and CGRP, 
but also substance P (SP) (Welle, 1997). Furthermore, chymase can convert IL-ip 
precursor into its active form and degrade IL-4 (Walls, 1998). In addition, chymase has a 
role in regulation of blood pressure because it converts angiotensin-l to angiotensin-ll, 
independently, and even more efficiently than angiotensin-converting enzyme (Welle, 
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1997; Walls, 1998). This chymase activity could be related with the high levels of 
angiotensin reported in some cases of acute asthma (Walls, 1998). 
The MC-deficient mice have also been useful to understand the relevant 
role of MCs in bacterial clearance and influx of polymorphonuclear cells (PMN) into sites 
of infection. These mutant mice are more susceptible to an intranasal challenge with 
Klebsiella pneumoniae when compared with MC-competent littermate controls (Malaviya 
et al., 1996a). Subsequently, MC-reconstituted W/W mice exposed to the same 
challenge respond more favorably to the bacterial challenge and do not present the 
Increased susceptibility (Malaviya et al., 1996a). This improved response to challenge 
was related to an increased alveolar exudation of polymorphonuclears (PMNs) attributed 
to various inflammatory mediators released by MCs, particularly tumor necrosis factor 
alpha (TNF-a) (Malaviya etal., 1996a). 
Similarly, WAA/^ mice had increased mortality in a model of acute septic peritonitis 
(caecal ligation and puncture) (Echtenacher ef a/., 1996). Reconstitution of these MC-
deficient mice with cultured MCs substantially increased their resistance, whereas anti 
TNF-a antibody injected after the peritonitis procedure suppressed this MC-transferred 
resistance (Echtenacher et al., 1996). The inflammatory response and the fibrin 
exudation mediated by MCs and MC-derived TNF-a, were believed to be the major 
factors in localizing and confining the bacterial infection, resulting in protective effects 
(Echtenacher et al., 1996). 
It has been suggested that bacteria can activate MCs by mechanisms distinct 
from those related to antigen recognition after opsonization (FCER, FcyR, and receptors 
for complement fragments) (Dreskin and Abraham, 1999). Mast cells possess a wide 
range of receptor molecules in their membranes, some of which mediate recognition of 
bacterial constituents such as fimbriae and lipopolysaccharides (Abraham et al., 1997; 
Dreskin and Abraham, 1999). Although these bacterial components induce MC 
activation, their specific receptors are still unidentified (Abraham et al., 1997). On the 
other hand, MCs are able to phagocytose and kill bacteria and present bacterial antigens 
through class I MHC molecules to CD8'^  T cells (Malaviya et al., 1996b). Additionally, 
MCs express class 11 MHC molecules and present processed immunogenic peptides to 
CD4'^  T cells (Mekori and Metcalfe, 1999). The presence of accessory molecules such 
B7 and ICAM-1 on the surface of MCs is consistent with their function as antigen-
presenting cells (Mekori and Metcalfe, 1999). 
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Mast cells are intimately related with the progression of the inflamnnatory 
response. During the acute stages MCs degranulate and become almost absent in sites 
of severe and acute inflammation (Cheville, 1994). The role of MCs during acute 
inflammation has been highlighted by the obsen/ation that MC degranulatlon prior to 
ischemia decreases ischemia-reperfusion Injury In the small Intestine of dogs (Boros et 
al., 1999). Similarly, In MC deficient mice (W/W and Sl/Sf), intravesical administration 
of LPS produced a mild reaction In comparison with normal controls (Bjorling et al., 
1999). The Inflammatory response occurs in animals lacking MCs but, as Indicated, the 
response is inadequate because neutrophil recaiitment is deficient; the defect Is 
probably dependent on TNF-a which is one of the major cytokines stored preformed In 
MCs (Malaviya et al., 1996a: Echtenacher et al., 1996). On the other hand, the presence 
of neutrophils during a normal inflammatory response is very important to MCs because 
neutrophil defenslns are potent MC secretagogues (Befus et al., 1999). In addition, 
activation of complement, particularly C3, Is undoubtedly required during acute 
Inflammation mediated by MCs (Prodeus etal., 1997). 
During the chronic stages of inflammation, Intraleslonal MCs proliferate (Metcalfe 
et al., 1997). In human beings MC hyperplasia Is a characteristic of many chronic 
disorders in the skin and lung and is accompanied by fibrosis (Levi-Schaffer, 1995). In 
some cases, the MC-fibroblast relationship has been demonstrated in animal models 
such as pulmonary fibrosis in rats Induced by bleomycin (Levi-Schaffer, 1995; Metcalfe 
et al., 1997). However, Okazaki et al. (1998) demonstrated that pulmonary fibrosis 
occurred when MC-deflcient rats (l/l/s/Ws) were exposed to bleomycin. They concluded 
that MC hyperplasia is commonly associated with, but not the cause of fibrosis. Apart 
from the proliferative influence of MC proteases on fibroblasts and smooth muscle cells 
already mentioned, MCs contain many compounds that affect fibroblasts and have 
angiogenic effects. For example, heparin and histamine Influence fibroblast proliferation, 
collagen synthesis and angiogenesis, and several cytokines and growth factors 
produced by MCs (IL-4, TNF-a, TGF-pi, NGF, basic fibroblast growth factor [bFGF]) 
have fibrogenlc-angiogenic activity (Levi-Schaffer, 1995; Metcalfe et al., 1997). Mast 
cell-fibroblast heterotypic contact activates MCs to produce IL-4, which promotes 
fibroblast proliferation (Trautmann et al., 1998), and fibroblasts engulf MC granules 
directly (Levi-Schaffer, 1995). Similar to the inadequate inflammatory response observed 
In models of acute inflammation in MC-deficient mice (Malaviya etal., 1996a; 
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Echtenacher et al., 1996), the fibroplastic (and angiogenic) changes that occur during 
the chronic stages of an inflammatory response in MC-deficient rats, may be defective 
as well. 
In normal human skin MCs have an important role in wound healing. By two days 
after incisional formation of a wound, MCs were largely absent in areas of necrosis and 
hemon^hage but were present in the surrounding viable tissue; however, between seven 
and fourteen days, MCs were increased in the fibrotic areas of the wound where the new 
matrix was formed (Trautmann et al., 2000). Trautmann and coworkers (2000) found that 
MCs were increased due to recruitment and did not replicate in situ. The chemotactic 
factor that promoted MC accumulation was monocyte chemotactic protein -1 (MCP-1) 
synthesized by macrophages and keratinocytes. Macrophage inflammatory protein-1a/p 
(MIP-1a, MIP-lp) and RANTES had no effect (Trautmann et al., 2000). In addition, MCs 
synthesized IL-4 which promotes fibroblast migration and proliferation, and fibroblast 
synthesis of collagen (Trautmann et al., 2000). The authors concluded that MCs are 
involved mostly in the late (anabolic) process of wound healing more than the earlier 
inflammatory (catabolic) period (Trautmann etal., 2000). 
Tachykinins 
Communication between the immune and neuroendocrine system is mediated by 
peptides and proteins that are used as intercellular messengers (Weigent and Blalock, 
1997). For example, cells of the immune system, in both primary and secondary 
lymphoid organs, are able to produce hormones and neuropeptides (e.g., corticotropin, 
thyrotropin, growth hormone, prolactin, and catecholamines, among others) (Savino and 
Dardenne, 1995; Weigent and Blalock, 1997), which also can exert cytokine-like effects 
(Torres and Johnson, 1997). Conversely, classical endocrine glands, epithelial cells, as 
well as neurons and glial cells, can produce a variety of cytokines that exert hormone­
like actions (Stadnyk, 1994; Savino and Dardenne, 1995; Smith, 1997; Weigent and 
Blalock, 1997; Benveniste, 1997). Moreover, receptors for honnones, neurotransmitters 
and cytokines are expressed in both cells of the immune and neuroendocrine systems 
(Garza Jr. and Can*, 1997; Walter, 1997; Weigent and Blalock, 1997). 
The widespread innervation of lymphoid organs and the close association of 
nerves with lymphocytes, macrophages, dendritic cells, and MCs is a clear indication of 
the cell to cell interaction between the nervous and immune systems (Goetzl et al., 1995; 
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Maggi, 1997; Stevens-Felten and Bellinger, 1997). Stimulated sensory nerves, 
particularly unmyelinated sensory nerve endings (C-fibers), release active neuropeptides 
and simultaneously transmit sensory information (Brain, 1997; Maggi, 1997). Substance 
P is one of the best-characterized neuropeptides, with demonstrated capability to induce 
the neurogenic inflammatory response; SP is also able to act as a modulator of the 
immune response (Maggi, 1997). More recently SP has been identified as an important 
mediator in the hypothalamic-pituitary-adrenal axis (Nussdorfer and Malendowicz, 1998). 
Substance P belongs to a family of small neuropeptides called tachykinins 
(Otsuka and Yoshioka, 1993; Maggi, 1997; Nussdorfer and Malendowicz, 1998). The 
name tachykinin refers to an ability to rapidly contract smooth muscle, as opposed to the 
effect of bradykinin (Reynolds et al., 1997). The tachykinin family is a group of small 
peptides characterized by the C-tenninal amino acid sequence Phe-X-Gly-Leu-Met-NHz, 
where X is either an aromatic (Phe) or branched aliphatic (Val) residue (Otsuka and 
Yoshioka, 1993; Piediminte, 1995; Maggi, 1997). Apart from SP, the other mammalian 
tachykinins are neurokinin A (NKA) and neurokinin B (NKB) (Otsuka and Yoshioka, 
1993; Piediminte, 1995; Maggi, 1997). 
Substance P and NKA are derived from the single preprotachykinin A (PPT-A) 
gene after alternate splicing of the primary RNA transcript. Neurokinin B is derived from 
a separate gene (PPT-B) (Piedimonte, 1995; Brain, 1997; Nussdorfer and Malendowicz, 
1998). The alternate processing of the PPT-A gene primary transcript give several forms 
of mRNAs, including the N-temiinal extended forms of NKA: neuropeptide K (NPK) and 
neuropeptide y (NPy) (Otsuka and Yoshioka, 1993; Piedimonte, 1995; Nussdorfer and 
Malendowicz, 1998). Preprotachykinin A gene expression is highest in the central and 
peripheral nervous systems whereas the PPT-B gene product occurs mostly in the brain 
(Rameshwar and Gascon, 1997). Preprotachykinin-A gene expression has also been 
demonstrated in non-neural cells such as Leyding cells of testis, endothelial cells, 
lymphocytes, monocytes, macrophages, eosinophils, neutrophils, and keratinocytes 
(Bae etaL, 1999). 
Substance P is present in all of the peripheral nen/es that contain cutaneous or 
visceral afferents and also in the central and peripheral projections of sensory neurons. 
Locations of peripheral sensory nerve endings containing SP that are particulariy 
prominent include the varicose terminal-like structures associated with blood vessels 
(including precapillary arterioles and venules) especially in epithelial surfaces, and free 
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nerve endings in epithelia of skin, cornea, respiratory and urogenital system. These 
structures are situated either just beneath the epithelium or extending to the epithelial 
surface. In addition, SP occurs in fascicles of varicose fibers and nerve endings in 
smooth muscle layers of visceral organs, and fibers in autonomic (parasympathetic, 
sympathetic pre- and paravertebral) ganglia where collaterals of afferent neurons make 
synaptic contacts with dendrites of the principal ganglion cells (Holzer, 1988). 
Ganglion neurons in the myenteric and submucosal plexuses of the 
gastrointestinal tract also produce tachykinins and this should be expected to occur in 
ain/vay ganglion neurons in the lung because of its embryonic development from the 
foregut (Dey etal., 1988). Nonetheless, the presence of SP in (intrinsic) ainway ganglia 
has not been consistently recognized in the lung. The discrepancy could be explained by 
the fact that airway ganglia contain a heterogeneous population of neurons susceptible 
to adaptive functions under physiological and pathological conditions (Perez Fontan et 
ai, 2000). 
The presence of tachykinins in primary and secondary lymphoid tissues is 
remarkable. Although the source of these mediators may be directly from the primary 
afferent nerves located in these lymphoid tissues (Stevens-Felten and Bellinger, 1997), 
the main sources appear to be endothelial cells, lymphocytes, eosinophils, macrophages 
and neutrophils. Preprotachykinin-A mRNA has been recognized in all of these cells 
(Maggi, 1997). Several factors influence the expression of the PPT-A gene, i.e., 
exposure to LPS upregulates whereas dexamethasone downregulates PPT-A gene 
expression in alveolar macrophages and pulmonary neutrophils (Killingsworth et al., 
1997). 
The agonistic activity of tachykinins is associated with the shared carboxy-
terminal domain whereas the amino-tenninal domain confers receptor specificity 
(Piedimonte, 1995). Three tachykinin receptors have been recognized, neurokinin 1-
receptor (NK-1R), NK-2R and NK-3R. Although each of the tachykinin peptides can act 
as a full agonist on all three receptors if present at sufficiently high concentration, there 
is a preferential binding tendency. For example, SP, NK-A, and NK-B exhibit binding 
preferences for NK-1R, NK-2R and NK-3R, respectively (Piedimonte, 1995; Garza Jr. 
and Carr, 1997). Ligand binding studies indicate subtypes of each receptor which 
probably recognize different amino terminal domains in the peptides (Piedimonte, 1995). 
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Structurally the NK-R consists of an extracellular amino terminus, seven 
hydrophobic transmembrane helices with alternating extracellular and cytoplasmic loops 
and a cytoplasmic carboxy temninus. This structure is compatible with that of G protein-
coupled receptors which mediate ceil activation through cAMP and a phosphatidylinositol 
pathway with a concomitant rise in cytosolic (Piedimonte, 1995; Garza Jr. and Carr, 
1997). 
The NK-1R and NK-2R are expressed in bone marrow stromal cells and mediate 
regulatory actions on hematopoiesis (Rameshwar and Gascon, 1997). It has been 
suggested that SP and NKA mediate their hematopoietic effects through the induction of 
cytokines and their receptors in bone man^ow stromal cells. Substance P exerts 
proliferative effects on hematopoiesis and its effects correlate with the induction of 
positive hematopoietic growth factors such as IL-3, IL-6, GM-CSF and SCF (Rameshwar 
and Gascon, 1997). Conversely, NKA exerts inhibitory effects on hematopoiesis and its 
actions correlate with the induction of two negative hematopoietic regulators, MIP-1a 
and TGF-|3 (Rameshwar and Gascon, 1997). The stimulatory effects on bone marrow 
progenitors is mediated by NK-1R (which preferentially binds SP) and its expression is 
influenced by cytokines, mainly IL-1, derived from bone marrow stromal cells stimulated 
by SP. Moreover, SP can induce the IL-1 type I receptor In stromal cells (Rameshwar 
and Gascon, 1997). Conversely, NK-2R (which binds preferentially NKA) downregulates 
the process (Rameshwar and Gascon, 1997). 
The NK-1 R and NK-2R receptors are also expressed in lymphocytes; their 
expression in T cells is associated with a modulatory influence on the immune response 
(McComiack et al., 1996; Maggi, 1997). The presence of NK-1R has been demonstrated 
mostly in T cells and under certain circumstances in B cells; the latter particularly in a 
human lymphoblastic cell line (IM-9) (Garza Jr. and Carr, 1997). In human peripheral 
blood NK-1R is expressed in T lymphocytes but not on B lymphocytes (Maggi, 1997). 
Approximately, 10% of CD8-*- T cells and 18% of CD4-»- T cells in circulating human 
blood express NK-1R (Tonres and Johnson, 1997). Similarly, in rodents, T cells located 
in the spleen and Peyer's patches express NK-1 R, as well as granuloma T lymphocytes 
in a murine model of schistosomiasis (McCormack etaL, 1996; Maggi, 1997). There is 
evidence that expression of NK-1R in T cells is constitutive (McCormack et al., 1996). 
Substance P activates T cells by inducing production of IL-2 (McCormack et at., 
1996). Some studies documented the influence of SP to enhance the production of 
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immunoglobulins, particularly IgA and IgM but not IgG (Goetzl et a/., 1995; Torres and 
Johnson, 1997). This promotion of the humoral response could be related with the 
expression of NK-R receptors on T cells and macrophages; thereby, the influence could 
be indirect due to the role of these cells in differentiation and maturation of 6 
lymphocytes (Maggi, 1997; Torres and Johnson, 1997). Nonetheless, there is evidence 
of direct action of SP on B cells. Substance P alone is not a sufficient stimulus for 
immunoglobulin production but rather acts synergistically with other agents, e.g., LPS 
(Maggi, 1997). 
The capability to respond specifically to SP could be related to the number of 
receptors expressed on the surface of the lymphocytes. It has been estimated that 
circulating T cells contains up to 7,000 sites for SP whereas splenic T and B cells have 
less than 200 (Garza Jr. and Carr, 1997). Furthermore, it has been proposed that B cells 
may also respond to SP by an NK-R receptor-independent mechanism. Apparently this 
mechanism requires relatively higher concentration of the peptide (laM) and could be 
operated as an additional pathway that employs a GTP binding protein, phospholipase D 
and MAP-Kinase (Garza Jr. and Carr, 1997). Substance P may act on B cells as a late 
differentiation cofactor (Maggi, 1997). Other actions of SP on lymphocytes include 
proliferation for T cells (Goetzl etal., 1995; Torres and Johnson, 1997), and promotion of 
lymphocyte homing (Goetzl et ai, 1995). The latter is probably due to enhanced 
expression of ICAM-1 on endothelial cells and increased avidity of LFA-1 on 
lymphocytes (Vishwanath and Mukherjee, 1996). 
Similarly, macrophages express the NK-1R and NK-2R receptors (Maggi, 1997). 
NK-1R receptor is expressed at a basal level in murine peritoneal macrophages but 
under exposure to LPS it is rapidly upregulated (Maggi, 1997). Alveolar macrophages 
also upregulate the NK-1R receptor after an immune-mediated lung Inflammatory 
response (Kaltreider et ai, 1997). As was already mentioned, macrophages are also a 
source of SP and its expression, particularly in alveolar macrophages, is upregulated by 
LPS (Killingsworth etai, 1997) or by an antigenic challenge in hypersensltized animals 
(Kaltreider et ai, 1997). 
Substance P stimulated macrophages can display a pro-inflammatory response 
that includes production of arachidonic acid metabolites, augmented oxidative 
metabolism and production of IL-1, IL-6 and TNF-a (Tonres and Johnson, 1997). 
Apparently, the profile of the immune and inflammatory response depends on the 
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presence of NK-1R or NK-2R. In this way macrophages regulate their own function, and 
that of neighboring cells, in an autocrine and paracrine manner (Maggi, 1997). 
Langerhans cells in the epidermis are in close association with peptidergic 
sensory nerve fibers and specifically bind SP. With this evidence it can be presumed that 
SP influences the epidermal immune response; apparently, by inhibiting the capability of 
Langerhans cells to present antigens (Stanieck et al., 1997). In the lung, dendritic cells 
are in close proximity to unmyelinated nerve fibers and bind SP. Dendritic cells display 
chemotactic activity toward graded concentrations of SP in vitro and SP promotes the 
accumulation of dendritic cells in vivo, but SP has no apparent effect on the antigen-
presenting functions of dendritic cells (Kradin etal., 1997). More recently it has been 
demonstrated that dendritic cells produce SP and may stimulate T cell proliferation 
(Lambrecht et a!., 1999). 
NK-1R receptor has also been recognized in endothelial cells and granulocytes, 
particularly in neutrophils and eosinophils; thereby, these cells are both sources and 
targets for the proinflammatory and immunomodulatory effects of tachykinins 
(Killingsworth et al., 1997; Maggi, 1997; Rameshwar and Gascon, 1997). These cells are 
considered targets for therapeutic regulation of the inflammatory effects of tachykinins. 
From studies in vitro it has been demonstrated that tachykinins influence several actions 
of granulocytes, including chemotaxis, phagocytosis, augmented oxidative metabolism 
and generation of derivatives from the arachidonic acid, improve their antibody-
dependent cell-mediated cytotoxicity, and favor the synthesis and release of IL-8 (Maggi, 
1997; Torres and Johnson, 1997). However, most of the studies have revealed that 
larger concentrations (^M) of tachykinins, SP in most cases, are required in order to 
observe these effects (Maggi, 1997; Torres and Johnson, 1997). These tachykinin 
concentrations are probably far from those expected during physiological conditions in 
neurogenic inflammation (Maggi, 1997; Tonres and Johnson, 1997). Nonetheless, the 
expression of adhesion molecules, an essential step for neutrophil extravasation and 
migration, has been shown to occur by the influence of SP on both PMNs and 
endothelial ceils (Baluk etal., 1995). The expression of E-selectin, P-selectin and ICAM-
1 was demonstrated in several lines of endothelial cells under the influence of SP 
whereas p2 integrins are expressed on PMNs (Maggi, 1997). Apparently, the adhesion 
of PMNs to SP-activated endothelial cells is mediated by a protein kinase C mechanism 
dependent on NK-1R (Tominaga etal., 1999). 
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The evidence of the role of a specific receptor for SP (NK-1R) is widely 
supported but many other factors could also have a direct influence on PMNs during the 
acute inflammatory response. In this respect, the role of NK-1 R receptor is essential to 
initiate and promote the exudation of neutrophils into the alveolar space in a model of 
immune-complex alveolitis, because disruption of the gene expressing NK-1 R results in 
a protective effect (Bozic et at., 1996). This observation confirms the role of NK-1R 
during neurogenic inflammation but the possibility of other stimuli involved, like 
complement activation and the consequent activation of MCs, is evident. Activation and 
release of pro-inflammatory mediators from other cells (macrophages and MCs) 
probably provide the major stimulus for granulocyte migration into the tissues during 
acute inflammation. However, the role of SP must be considered because NK-R 
receptors are present in all of the cellular components of the inflammatory response: 
endothelial cells, granulocytes, macrophages, and MCs. Furthermore, all, but MCs, 
express the PPT-A gene (Maggi, 1997). 
There are several morphological studies that support the concept of a close 
relationship between MCs and sensory nerve endings containing SP and CGRP. This 
close proximity has been demonstrated in thymus, lymph nodes, dura mater, joints, 
ainways, urinary bladder, Intestine, and skin (Maggi, 1997; Metcalfe eta!., 1997). 
Furthermore, during processes of chronic inflammation, there are more MCs and their 
contacts with nerve fibers Increases (Metcalfe et al., 1997). In some cases, such as 
psoriatic lesions in humans, these Increased contacts between nerve fibers and MCs are 
predominantly with SP and CGRP fibers (Naukkarinen et al., 1996). 
As was indicated, MCs are one of the most Important components of neurogenic 
inflammation. The influence of SP on MCs occurs through the specific receptor NK-R1 
(Okada etal., 1999; Suzuki etal., 1999), and SP induces MC activation and 
degranulation at fiM concentrations (Maggi, 1997; Metcalfe etal., 1997). Moreover, NKA 
also induces MC degranulation (Cross et al., 1997). Nonetheless, there is evidence that 
SP-induced MC degranulation could also involve an alternate mechanism. Physiological 
concentrations of SP (and NKA) may exert their effect by priming MCs through their NK-
1R, making them more sensitive to degranulation via a tachykinin receptor-independent 
mechanism, like an electric field stimulatory effect (Hua et al., 1996). 
More recently a new role of MCs in inducing neurogenic Inflammation has been 
recognized. This mechanism Includes MC-tryptase acting as signaling molecule on 
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specific PAR2 which are expressed in sensory nerves that release neuropeptides after 
activation (Brain, 2000). Steinhoff et al. (2000) have demonstrated co-localization of 
PAR2 and CGRP and SP in a large proportion of primary spinal afferent neurons. 
Furthermore, the edema resulting from employing PAR2 agonists is markedly inhibited 
by antagonists of the CGRP-receptor and NK-1R, as well as by ablation of spinal 
afferent C-fibers (Steinhoff et al., 2000). 
From the previous report it is evident that the functional relationship of MCs and 
sensory nerves is reciprocal. Under physiological conditions MC activity is subjected to a 
positive control by neuropeptides which favors histamine release. Subsequently, a 
negative control is exerted by histamine acting on H3 receptors located on sensory nerve 
endings, inhibiting the release of neuropeptides (Nemmar et al., 1999). Additionally, the 
neurotrophin NGF is produced by MCs (Leon et al., 1994; Aloe et al., 1999). This MC-
production of NGF could explain the inductive effect on neurite formation in neurons 
maintained in culture under the influence of MCs (Blennerhassett, 1994). It has been 
suggested that during an inflammatory process, MCs could control the adaptive plasticity 
of the sensory nen/es due to their ability to produce NGF (Leon et al., 1994). 
The biological effects of tachykinins are modulated by enzymes expressed on the 
cell surfaces that degrade the peptide agonists in the proximity of their receptors. These 
membrane-bound peptidases are neutral endopeptidase (NEP, also called 
enkephalinase and common acute lymphocytic leukemia antigen, CD10/CALLA), 
angiotensin converting enzyme (ACE, also called kininase II) (Piedimonte, 1995), and 
dipeptidylpeptidase IV (DPP IV, also known as CD26) (Covas et al., 1997). The action of 
these peptidases is more evident by inhibiting the neurogenic inflammatory response in 
which NEP has a major role (Reynolds et al., 1997). The major source of NEP is the 
intact epithelium; thereby, epithelial damage may provide indirectly, an enhanced 
tachykinin effect (Piedimonte, 1995; Reynolds et al., 1997). On the other hand, 
CD10/CALLA and DPP IV/CD26 are also expressed as surface peptidases on T 
lymphocytes and probably play a modulatory role in the effects of SP on T cell function 
(Covas etal., 1997). 
The term neurogenic inflammation describes the increase in vascular 
permeability induced by neuropeptides, mainly SP, released from stimulated sensory 
nerves. Neurogenic inflammation occurs in many organs and tissues but because the 
skin and the airways are highly innervated by nerve fibers that contain neuropeptides. 
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these sites are particularly prone to neurogenic inflammation (Baluk, 1997). Several 
irritant compounds induce neurogenic inflammation as well as antidromic electrical 
stimulation of sensory nerves; however, capsaicin has been employed as a valuable tool 
for induction of neurogenic inflammation (Holzer, 1988; Baluk, 1997). The compound 
capsaicin is a pungent substance contained in hot peppers of the genus Capsicum that 
induces release of SP from sensory nerve fibers (Govindarajan and Sathyanarayana, 
1991). 
During neurogenic inflammation, the stimulation of sensory nerves by capsaicin 
induces vasodilatation and promotes edema. The latter effect is mediated by the 
fonnation of gaps between the endothelial cells at the postcapillary level. Concomitantly, 
granulocytes (neutrophils and eosinophils) adhere to endothelial ceils on postcapillary 
venules and eventually migrate into the inflamed tissues (Baluk, 1997; Brain, 1997; 
Maggi, 1997). During the Initiation of the inflammatory process the neurogenic 
component of the inflammatory response is more predominant but later, the participation 
of other inflammatory mediators (vasoactive amines, cytokines and derivatives of the 
arachidonic acid) become more relevant (Baluk, 1997). Therefore, SP, the best 
characterized mediator of neurogenic inflammation, directly elicits an inflammatory 
response but also contributes indirectly by inducing release of vasoactive compounds 
from MCs (Baluk, 1997). In addition, tryptase released from degranulated MCs may 
exerts a positive feedback through activation of PAR2 located on sensory nerves 
inducing a further release of SP and CGRP (Steinhoff et al., 2000). 
Capsaicin interacts with speciflc vanilloid receptors, i.e. vanilloid receptor-1 
(VR1), located on the entire membrane of the vanilloid-sensitive neurons (Szallasi and 
Blumberg, 1999). The VR1 is a vanilloid-operated nonspecific cation channel that, when 
activated, permits an influx of Na"^, and predominantly Ca^*. This action drives the 
generation and propagation of an afferent nerve impulse and release of tachykinins 
(Szallasi and Blumberg, 1999). Because not only vanilloids but noxious heat and low pH 
also activate the VR1 channel, the current concept is that VR1 functions as a molecular 
integrator of noxious chemical and physical stimuli. It is possible that heat is the real 
opener for VR1 and that capsaicin and low pH sen/e to reduce the heat activation 
threshold of the receptor (Szallasi and Blumberg, 1999). Although MCs are involved 
during induction of neurogenic inflammation induced by capsaicin, their role was 
originally thought to be indirect due to released tachykinins and their consequent 
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activation (Baluk, 1997). However, recently, it has been determined that MCs also 
express the VR1 and can be directly affected by capsaicin (Biro et al., 1998). 
The effects of capsaicin can be divided into three main types; excitation and 
release of tachykinins with a consequent acute inflammatory response, followed by a 
refractory state (desensitization) to a subsequent stimulus. This effect could be 
reversible if the dose is small and unique. However, if capsaicin is administered during 
certain periods and/or in large doses, an irreversible desensitization occurs due to 
neurotoxicity (Holzer, 1988; Baluk, 1997). Mechanisms proposed for capsaicin 
neurotoxicity include a massive Ca^" influx that leads to swollen mitochondria and 
activation of calpain, a Ca^ '^-dependent protease; also, the large Influx of Na^ 
accompanied by a passive movement of chloride resulting in accumulation of water and 
osmotic lysis has been proposed. Another mechanism postulates that NGF deprivation 
causes neurotoxicity in neonatal animals because capsaicin blocks the intra-axonal 
transport of macromolecules, including NGF (Fox, 1995). In this regard, NGF has an 
Important role in development and maintenance of neurons during neonatal life and 
could explain the high sensitivity of the newborn to capsaicin (Fox, 1995). In addition, 
there is an NGF-responsive element required for expression of the PPT-A gene and 
thus, in absence of NGF, SP (and NK-A) expression is down-regulated (Szallasi and 
Blumberg, 1999). More recently it has been reported that the neuronal damage induced 
by capsaicin in newborn rats occurs mostly by apoptosis and that the mechanism 
depends, at least partially, on deprivation of NGF (Sugimoto et al., 1998). 
Evidence obtained from the use of tachykinins and the selective blockage of their 
receptors have demonstrated that vascular and airway smooth muscle cells and 
submucosal glands in the respiratory tract express NK-1R and NK-2R (Piedimonte, 
1995). In the respiratory tract SP promotes ciliary beating, mucous secretion, pulmonary 
aioA/ay constriction, and an increase in the pemneability of the lung microvasculature 
(Otsuka and Yoshioka, 1993; Piedimonte, 1995). In addition, it has been suggested that 
SP may modulate epithelial cell proliferation during lung development (Sunday, 1997). 
On the other hand, SP and NKA have the capability to induce proliferation of lung 
fibroblasts (Harrison etai, 1995). 
From experiments in animal models of asthma, it has been generally accepted 
that tachykinins, particulariy SP, might have a role in its pathogenesis (Lundberg, 1995; 
Piedimonte, 1995; Reynolds et al., 1997). The models propose that the tachykinin-
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degrading enzymes (NEP, ACE) are decreased due to epithelial damage; this could 
result in an exaggerated and uncontrolled activation of the otheoA/ise physiological 
mechanisms dependent on tachykinins. Another explanation could be an increase in 
tachykinin concentration due to augmented content of neuropeptides in nerve terminals 
or proliferation of the SP-containing nerves. Similarly, it has been proposed that a 
neurogenic overreaction could occur due to augmented expression of NKR (Piedimonte, 
1995). Piedimonte and coworkers (1999) demonstrated an exacerbated response to SP 
in adult rats infected with respiratory syncytial virus due to increased expression of NK-
1R in airway epithelium and walls of blood vessels; conversely, the NEP activity was not 
significantly affected. These results could explain why some respiratory viruses 
potentiate neurogenic inflammation and exacerbate asthma in children (Piedimonte, 
1995). 
In animal models of asthma the allergen challenge causes an immediate 
response characterized by airway smooth muscle contraction due to MC-derived 
mediators, mainly histamine and leukotrienes. Subsequently, during the delayed phase, 
interstitial edema and mucous secretion occurs as the result of the Inflammatory 
response (Mashito et al., 1999). Apparently, neurogenic inflammation has a more 
important role during the delayed rather than the immediate asthmatic response 
(Mashito et al., 1999). It has been proposed that bradykinin may cause neurogenic 
inflammation during the delayed response due to a potent stimulatory action on C-fibers 
inducing them to release SP (Mashito et al., 1999). Conversely, in animal models of 
chronic bronchitis, the role of SP nerve fibers appears protective and limits or delays the 
inflammation occuring during chronic ain^/ay insult, probably as an adaptive response 
(Drazen eta!., 1999; Long etal., 1999). 
The prevailing concept of neurogenic inflammation in the lung is that SP and 
other neuropeptides are released from sensory nerve fibers that have their cell bodies 
located mainly in the nodose ganglion of the vagus with lesser numbers in the thoracic 
dorsal root ganglia (Baluk, 1997; Reynolds et al., 1997). Nonetheless, it has been 
convincingly demonstrated that ainway (intrinsic) ganglion neurons in the lung produce 
SP and also express the NK-1R (Perez Ronton et al., 2000). Indeed, syngeneic lung 
grafts, which lack (extrinsic) peptidergic sensory fibers, are able to mount an immune-
complex mediated inflammatory response in the lung that depends on NK-1R activation 
(P^rez Fontan et al., 2000). Therefore ganglia-released tachykinins may act in a 
23 
paracrine and autocrine fashion to regulate neurogenic inflammation in the lung (Perez 
Fontan et al., 2000). 
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CHAPTER 3. REDUCTION OF PULMONARY MAST CELLS IN AREAS OF ACUTE 
INFLAMMATION IN CALVES WITH MANNHEIMIA (PASTEURELLA) HAEMOLYTICA 
PNEUMONIA 
A paper accepted for publication (12/20/99) In Journal of Comparative Pathology 
R. Ramirez-Romero, K. A. Brogden, J. M. Gallup, R. A. F. Dixon and M. R. Ackermann 
Summary 
Mast cells in the left cranial pulmonary lobe of colostrum-deprived neonatal calves were 
quantified 2 and 6 h after intrabronchial inoculation with Mannheimia {Pasteurella) 
haemolytica A1. The mast cells were detected (1) immunohistochemically with a mouse 
anti-human mast cell tryptase monoclonal antibody, and (2) by metachromatic staining 
with low pH toluidine blue. A greater number of mast cells was demonstrated by the 
second method than by the first. At 6 h after inoculation, but not at 2 h, the number of 
mast cells was significantly reduced at the site of the main lesions. Treatment of calves 
with a sialyl Lewis mimetic (TBC1269) did not appreciably affect the results at 6 h. 
Introduction 
Apart from their role in the IgE-mediated immune response, the relevance of mast cells 
in non-specific pulmonary defence mechanisms is being recognized increasingly 
(Abraham et al., 1997). In the respiratory tract, mast cells are essential for bacterial 
clearance (Malaviya et al., 1996). Furthermore, mast cells produce an an-ay of cytokines 
and vasoactive compounds that mediate the acute inflammatory response (Malaviya et 
al., 1996; Abraham etal., 1997; Metcalfe etal., 1997). 
Pasteurella haemolytica A1, the bacterium most frequently isolated from natural 
cases of pneumonic pasteurellosis in cattle (Whiteley et al., 1992), has been recently 
reclassified as Mannheimia haemolytica (Angen et al. 1999). The pathogenesis of acute 
lung injury in bovine pneumonic pasteurellosis is complex and the inflammatory cells and 
their products have not been fully characterized (Whiteley et al., 1992). Few studies 
have assessed the role of mast cells in this pneumonic syndrome. However, Adusu et al. 
(1994) reported that mast cells recovered from cattle infected experimentally with M. 
haemolytica release increased amounts of histamine in vitro-, and M. haemolytica 
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leukotoxin and lipopolysaccharide both cause an increase in the spontaneous release of 
histamine from isolated bovine lung parenchyma (Saban etal., 1997). 
Although the distribution and quantification of mast cells in the bovine lower 
respiratory tract have been described (Chen et al., 1990; Kuther et al., 1998), there have 
been no studies on the influence of the acute inflammatory response induced by M. 
haemolytica on the numbers of mast cells in the bovine lung. Kimman et al., (1989), 
however, reported a reduced number of mast cells in the lungs of cattle during the acute 
phase of natural Infection with bovine respiratory syncytial virus. Cheville (1994) 
suggested that the number of recognizable mast cells decreases during an acute 
inflammatory response due to their degranulation. 
The aim of the present study was to investigate (1) the effect of M. haemolytica 
infection on the number of pulmonary mast cells, the work of Abraham et al. (1997) 
having already suggested that such cells react to gram-negative bacteria, and (2) the 
effect of a synthetic analogue (TBC1269) of sialyl Lewis (the natural ligand of the 
selectin family of leucocyte adhesion molecules), which competes with sialylated 
oligosaccharides, inhibiting the adhesion of selectins in vitro (Kogan etal., 1998), and 
might therefore exert an in vivo effect on mast cells. 
Materials and Methods 
Animals and Treatments 
Colostrum-deprived, Holstein male calves aged 1-3 days were obtained from Iowa State 
University Dairy Farms and maintained in isolation rooms in accordance with the 
methods approved by the American Association for Accreditation of Laboratory Animal 
Care and the University Animal Care Review Committee. The animals were randomly 
assigned to five groups. Group 1 (three control animals) which received pyrogen-free 
saline, were killed at 2 h post-inoculation. Group 2 (four animals) were inoculated with 
10^ colony-forming units (cfu) of M. haemolytica and killed at 2 h post-inoculation. Group 
3 (three control animals) which received pyrogen-free saline, were killed at 6 h. Group 4 
(four animals) were inoculated with 10^ cfu of M. haemolytica and killed at 6 h post-
inoculation. Group 5 (four animals), which received TBC1269 (Texas Biotechnology 
Corp., Houston, Texas) in pyrogen-free saline (0.9%) intravenously (25 mg/kg) 30 min 
before and 2 h after inoculation with 10^ cfu of M. haemolytica, were killed at 6 h post-
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inoculation. Euthanasia was carried out with an intravenous overdose of sodium 
pentobarbital. 
Intrabronchial Inoculation and Collection of Tissues 
Saline and M. haemolytica suspension, in volumes of 5 ml, were deposited in the left 
cranial bronchi by fiberoptic bronchoscopy as previously described (Brogden et a!., 
1995; Ackermann et al., 1996). Samples of lung from the animals receiving M. 
haemolytica inocula were collected from the site of the inoculum deposition (site 2) and 
from two adjacent sites, cranial (site 1) and caudal (site 3) to the lesion. Equivalent 
samples were collected from the control animals that had received saline. The samples 
were fixed in buffered 10% formalin. 
Histological and Immunohistochemical Examination 
The samples were embedded in paraffin wax, sectioned (4 |am) and stained with 
haematoxylin and eosin (HE), Giemsa, astra blue, toluidine blue, low pH toluidine blue, 
and immunohistochemically for tryptase. Except for HE, which was employed for 
evaluation of histological changes, the stains were used for the recognition of mast cells. 
Low pH toluidine blue and tryptase staining were carried out as described by Chen et al. 
(1990) and Kuther etal. (1998), respectively. 
Immunohistochemical examination was made with a primary monoclonal mouse 
antibody (anti-human skin mast cell tryptase) recommended for formalin-fixed, paraffin 
wax-embedded tissue sections (Mast Cell, AA1; Dako, Carpinteria, California). Briefly, 
the slides were heated in an oven for 30 min at 58°C, dewaxed In xylene and treated 
with a succession of graded alcohols. Subsequently, they were subjected to an antigen 
retrieval process which included heating the slides to boiling (c. 1.5 min) in citrate buffer 
(pH 6.0) followed by an extended heating (c. dS'C) for 10 min. They were then pre-
digested with 0.1 % protease XIV (Sigma, St Louis, Missouri) at 37°C for 5 min. The 
primary antibody was applied at a 1 in 50 dilution and the slides were incubated for 1 h 
at room temperature. The secondary antibody, affinity-purified biotinylated goat anti-
mouse (KPL, Gaithersburg, Maryland), was employed at 1 in 200 dilution and the slides 
were incubated for 30 min. The procedure included a 30- min treatment with super­
sensitive alkaline phosphatase (BioGenex, San Ramon, California) applied followed by 
two 30-min applications of Histomark Red (KPL, Gaithersburg, Maryland). All of these 
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steps were carried out in an OptiMax® Plus automated cell staining system (BioGenex). 
The slides were counterstained with haematoxylin for 20 sec, dehydrated through 
alcohols, cleared in Pro-Par (Anatech Ltd. Battle Creek, Michigan) and coverslipped. 
Negative controls omitting the primary antibody were included. 
Procedure for Counting Mast Cells and Statistical Analysis 
Mast cells were counted in 20 high-power (x 400) fields (equivalent to c. 3.694 mm^) and 
expressed In cells/mm^, as described by Chen et si. (1990). The fields were randomly 
selected on each slide with no premeditated intention to avoid empty spaces except for 
the lumina of large ainvays or large blood vessels. A first counting procedure included 
the three sites (1, 2, and 3) in infected and control animals. There were usually two 
slides from each site, each slide bearing two lung sections, but only a single section, 
randomly selected, from each of sites 1-3, was used; the result for each animal was the 
mean value obtained from the three sites. In a second counting procedure sites 1 and 3 
were excluded, mast cells being counted only in site 2; average values were obtained 
from counting three sections except in two animals from which only two sections were 
available. 
The data were analysed in a completely random design with the model Yij=M + 
ri + aj. Subsequently, a Tukey's w procedure was used for specific comparisons (Steel 
etal., 1997). 
Results 
Gross Lesions and Histopathology 
Macroscopically, all of the animals inoculated with M. haemolytica (groups 2, 4 and 5) 
showed characteristic lesions of pneumonic pasteurellosis, including consolidation with 
zones of haemon-hage and variable amounts of fibrin on the pleural surface. These 
lesions ranged from moderate to severe and were always confined to the site of 
deposition of the inocula. Animals killed at 6 h post-inoculation had the more severe 
changes. The main lesions, which varied in diameter from 4 to 8 cm, were confined to 
site 2; the adjacent areas (sites 1 and 3) showed mild congestion and oedema. Control 
animals (groups 1 and 3) had no lesions. Microscopically, site 2 in the lungs of the 
infected animals had a moderate to severe suppurative orfibrinosuppurative 
bronchopneumonia and extensive areas of alveolar oedema and haemorrhage; these 
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were multifocal, the foci sometimes coalescing. The lesions in the adjacent sites 1 and 3 
were characterized by interstitial and alveolar oedema with neutrophils within the 
interstitium and bronchioles and adjacent alveolar spaces; these lesions were 
considered mild and had a diffuse distribution with interspersed areas of nomnal tissue. 
The control animals showed mainly normal tissue with some discrete areas of thickening 
of the alveolar septa due to interstitial oedema. There was no evidence of inflammatory 
response. 
Mast Cells 
The criteria for optimal detection of mast cells were (1) distinctive staining, enabling mast 
cells to be recognized at medium (x 100) power, and (2) absence of interfering 
background. The immunohistochemical procedure for tryptase proved to be the best 
method for producing distinctive staining, followed by low pH toluidine blue. Mast cells in 
sections treated immunohistochemically had deeply stained, bright red cytoplasm (Fig. 
1B, inset), whereas low pH toluidine blue gave the characteristic metachromatic 
appearance of mast cell cytoplasm (Fig. 1 A and 6). When the two procedures were 
used on replicate sections from randomly selected animals, higher numbers of mast 
cells were detected (P<0.01) with the low pH toluidine blue stain. The analysis for 
comparison was a Student's t test, assuming independent samples and unequal 
variances (Steel et al., 1997). Tryptase staining yielded a result of 0.507 ± 0.394 mast 
cells/mm^ (mean ± SD; n=8), whereas low pH toluidine blue yielded 5.210 ± 2.655 mast 
cells/mm^ (mean ± SD; n=8). The latter method was therefore chosen for comparing the 
different animal groups. 
In the comparison made by the first counting procedure (average of values from 
sites 1-3) analysis of variance (ANOVA) indicated differences between the groups of 
animals but not at a statistically significant level (P>0.05) (Table 1). However, the 
comparison made by the second counting procedure (average of values from site 2) 
revealed highly significant differences between groups (P<0.005). A posterior analysis of 
the data made with Tukey's w procedure (Steel et al., 1997) demonstrated that calves 
inoculated with M. haemolytica and killed 6 h later (Groups 4 and 5) had reduced 
numbers of mast cells as compared with controls (Groups 1 and 3) (P<0.05). Calves in 
Group 2, also inoculated with M. haemolytica but killed 2 h later, also had reduced 
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numbers of mast cells but the reduction was not statistically significant (P>0.05). 
Differences were not detected between the Infected groups (2, 4 and 5) (Table 2). 
Discussion 
The decreased number of mast cells In the lung of calves inoculated with M. haemolytica 
was restricted to the site of the main lesions. This decrease was statistically significant at 
6 h post- inoculation but not as early as 2 h. Mast cells were particularly scarce In areas 
with severe damage, characterized by fibrinopurulent or fibrinohaemorrhagic pneumonic 
lesions. However, when less affected areas adjacent to the site of severe lesions were 
Included In the comparisons, the numbers of mast cells were reduced but not to a 
statistically significant level. This suggests that the disappearance of mast cells due to 
degranulation during an acute Inflammatory response (Cheville, 1994) Is intimately 
related to the intensity of the lesion and the time of exposure. Furthermore, this confirms 
the relevant role of mast cells during an acute inflammatory response, particularly In the 
lung. 
It has been postulated that mast cells represent one of the most important means 
of defence in the lung In both Innate and immune responses (Abraham et ai, 1997). In a 
mouse model of pneumonia produced by Klebsiella pneumoniae, mast cells were 
necessary for modulating the lung inflammatory response and bacterial clearance 
(Malavlya et ai, 1996); these effects were mainly attributed to the release of tumour 
necrosis factor-alpha (TNF-a) from mast cell granules. Additionally, mast cells contain a 
vast array of pro-Inflammatory cytokines, such as interleukin-1 (IL-1) and lnterleukin-8 
(IL-8) (Abraham etai, 1997; Metcalfe et al., 1997). Increased amounts of these 
cytokines have been demonstrated in the lungs of cattle with pneumonic pasteurellosis 
(Yoo et a!., 1995; Caswell et al., 1998). 
Chen et al. (1990) reported that with low pH toluidine blue, formalin and Isotonic 
formalin-acetic acid fixation resulted in similar numbers of stained pulmonary mast cells. 
The same authors found that the number of mast cells was dramatically lower (c. 12 
mast cells/mm^) in 8-day-old calves than in adult cattle. In the present study c.7 mast 
cells/mm^ were recognized in the controls, but the calves were younger than those 
examined by Chen etai (1990). 
Mast cell proteases are considered to be the most specific markers for mast cells 
(Metcalfe etai, 1997; Welle, 1997). Tryptase-positive mast cells form the great majority 
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(>95%) of mast cells In the bovine lung (Kuther et a/., 1998; Jolly et al., 1999). For 
demonstration of mast cell proteases, Kuther et al. (1998) reported that the use of 
Camoy's fixative was preferable to fomnalin fixation, but the difference was not 
statistically significant in the lungs of adult cattle; the authors suggested that mast cells 
from various tissues exhibited different sensitivity to formalin and that bovine mast cells 
were relatively formalin-resistant. However, Kuther et al. (1998) employed a polyclonal 
rabbit anti-human mast cell tryptase antibody, whereas we used a monoclonal mouse 
anti-human antibody. Nonetheless, the results in quality of staining were comparable 
but, as already mentioned, the number of cells demonstrated immunohistochemically 
was less than that stained by low pH toluidine blue. More recently. Jolly et al. (1999) 
reported that a monoclonal mouse anti-human skin mast cell tryptase antibody worked 
well in recognizing tryptase-positive mast cells in the bovine lung; however, as in the 
present study, higher numbers of mast cells were detected with low pH toluidine blue 
stain. Jolly et al. (1999) suggested that one of the reasons for this discrepancy was the 
high specificity but lack of sensitivity of this monoclonal antibody; an alternative 
possibility was that the type of tryptase produced by bovine mast cells was unable to 
react readily with the monoclonal antibody employed. 
Mast cell density and staining properties may be influenced by a number of 
factors, including age and health. In the rat, mast ceils have not been recognized In the 
fetus (Jeffery, 1998) and are very scarce in the newborn (Wilkes et al., 1992). Mast cells 
arrive in an immature state of differentiation in the tissues in which they complete their 
maturation (Metcalfe et al., 1997). Here they first express proteoglycan (heparin); the 
expression of the proteases occurs at the end of the process in mature mast cells 
(Welle, 1997). It is possible, therefore, that the numbers of mature mast cells expressing 
tryptase were low in the present study because of the young age of the calves. 
Metachromatic staining of immature mast cells may be possible as the result of early 
expression of a proteoglycan matrix in their granules. 
In a model of viral bronchiolitis in rats infected with Sendai virus, increase in the 
number of mast cells resulted from both a proliferation of pre-existing mast cells and an 
augmented recruitment of circulating mast ceil precursors, but a significant increase in 
mast cells occurred only after day 14 post-infection (Sorden and Castleman, 1995). 
Conversely, during acute episodes of naturally occurring bovine respiratory syncytial 
virus infection, the numbers of pulmonary mast cells decrease (Kimman etaL, 1989); 
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furthermore, the lungs of the virus-infected cattle contained an increased proportion of 
degranulated mast cells. Our observations were compatible with the results of Kimman 
efa/.(1989). 
Since the synthetic compound TBC1269 is a potent inhibitor of selectin-mediated 
cell adhesion in vitro (Kogan, et al., 1998), we suspected that reducing the infiltration of 
neutrophils would have an effect on mast cell degranulation. This assumption is 
supported by recent work by Befus et al. (1999) who demonstrated that neutrophil 
defenslns induce mast cell degranulation. However, the decreased numbers of mast 
cells in TBC1269-treated animals (Group 5) were not significantly different from those 
animals receiving the bacteria alone (Groups 2 and 4). Thus, TBC1269 did not prevent 
the initial degranulation of mast cells. Similarly, in a mouse model of mast-cell 
dependent inflammation in the skin, degranulation of mast cells was not prevented in 
mice genetically incapable of producing P- and E-selectins (de Mora et al., 1998). 
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Figure 1. Sections of lung corresponding to site 2, the site with the main lesion in an 
animal that received M. haemolytica (A) and its equivalent in a control that received 
saline (B), both killed at 6 h post-inoculation. In picture A, there is a single mast cell 
partially degranulated in an area with extensive consolidation. Low pH toluidine blue. 
x400. In picture B, there are several mast ceils and no tissue damage. Low pH toluidine 
blue. x200. The inset shows a single tryptase-positive mast cell. Immunolabelling. x400. 
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Table 1 
Numbers of mast cells (means obtained from sites 1-3) in calves of Groups 1-5 
Mean numbers of mast cells/mm^ in sites 1-3 at 
2 h after inoculation 6 h after inoculation 
calves of Grouos calves of Grouos 
Individual 1 (controls; 2 (infected; 3 (controls; 4 (infected; 5 (infected 
calves In n=3) n=4) n=3) n=4) and TBC1269-
5 Groups treated; n=4) 
1 7.57 8.84* 7.12 4.96 4.14 
2 6.58 2.25 6.49 4.14 3.66 
3 4.60 3.99 5.95 2.25 3.03 
4 » . . r 4.78 .... 2.52 1.92 
MeaniSD 6.25^±1.51 4.96^±2.79 6.52^10.58 3.46^±1.29 3.18^±0.95 
* This animal showed the least severe lesions of all infected animals. 
^ These values were not significantly different from each other (ANOVA; P>0.05). 
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Table 2 
Numbers of mast cells (means obtained from site 2) in calves of Groups 1-5 
Mean numbers of mast cells/mm^ in site 2 at 
2 h after inoculation 6 h after inoculation 
calves of Grouos calves of Groups 
Individual 1 (controls; 2 (infected; 3 (controls; 4 (infected; 5 (infected 
calves in n=3) n=4) n=3) n=4) andTBC1269-
5 Groups treated; n=4) 
1 8.11 9.06* 7.57 3.24 2.79 
2 8.28 1.98 6.49 2.83 3.78 
3 5.27 3.80 8.02 3.15 1.89 
4 4.05 1.98 1.35 
Mean±SD 7.22®±1.69 4.72®''±3.03 7.36®±0.78 2.80''±0.57 2.45''±1.06 
*This animal showed the least severe lesions of all infected animals. 
^ Values not sharing a superscript letter are significantly different (Tukey's wtest; 
P<0.05). 
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CHAPTER 4. DIHYDROCAPSAICIN TREATMENT DEPLETES PEPTIDERGIC NERVE 
FIBERS OF SUBSTANCE P AND ALTERS MAST CELL DENSITY IN THE 
RESPIRATORY TRACT OF NEONATAL SHEEP 
A paper submitted for publication (12/13/99) to Regulatory Peptides 
Rafael Ramirez-Romero, Jack M. Gallup, loana M. Sonea, Mark R. Ackermann 
Abstract 
In the present study we administered dihydrocapsaicin (DHC) to neonatal lambs 
to deplete C-fibers of neuropeptides. We measured the density of substance P (SP)-
fibers in nasal septum to assess the effectiveness of the treatment at 3, 9, and 21 days. 
The numbers of mast cells in the upper and lower respiratory tract were detennined at 
the same time points and histamine content was determined from lung tissue. DHC 
treatment depleted SP-fibers for up to the 21 day time point. This depletion was 
estimated as 85% in comparison with controls. In vehicle-treated lambs, the density of 
SP-fibers decreased progressively with age, but not to the degree of DHC-treated lambs 
whose SP-fibers were depleted from the initial 3-day measurement. In both vehicle- and 
DHC- treated lambs, numbers of mast cells increased progressively with time; however, 
the density of mast cells was augmented in the entire respiratory tract of DHC-treated 
animals. Apparently, DHC treatment exerts a single and initial effect in increasing mast 
cells whereas time maintains a continuous influence; both factors exert their influence 
independently. Despite large numbers of mast cells in DHC-treated animals, histamine 
content in the lung had similar levels as controls. Our study provides fundamental data 
for a better understanding of conditions that may influence defense mechanisms 
dependent on the mast cell-SP nen/e axis in the respiratory tract. 
1. Introduction 
The relevance of mast cells in the defense mechanisms of the respiratory tract has been 
increasingly appreciated [1]. In the lung, mast cells are necessary for modulating the 
acute inflammatory response and clearance of bacteria [2]. Furthermore, mast cells are 
able to present antigens to lymphocytes favoring an interaction that modulates the 
immune response [3]. On the other hand, mast cells are closely related, physically and 
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functionally, to sensory nerve fibers in the respiratory tract [4-6]. The mast cell-nerve 
relationship, considered the prototype of the neuroimmune interaction, is provided by the 
neuropeptide substance P [7]. Substance P (SP) is a tachykinin released mostly from 
unmyelinated sensory nerves (C-fibers) that acts through a specific receptor on mast 
cells (NK-1 receptor), inducing their degranulation [7]. However, the communication is 
reciprocal and histamine released from mast cells can act on specific (H3) receptors 
located on C-fibers [6,8-10]. Abnormalities in this nerve-mast cell circuit have been 
postulated to occur in pathological states such as asthma [6,7]. 
Capsaicin and dihydrocapsaicin (DHC), the most potent of the capsaicinoids, are 
natural compounds present in hot peppers of the genus Capsicum, which confer the 
pungent taste to these fruits [11]. Capsaicinoids act through receptors, i.e. vanilloid 
receptor-1, located mostly in small primary sensory (afferent) neurons and their C-fibers, 
inducing them to release neuropeptides such as SP [12]. For this reason, capsaicin has 
been widely used to study the mechanisms of neurogenic inflammation [13,14]. The 
effects of capsaicin can be divided in three main types; a) excitation and release of 
tachykinins with a consequent acute inflammatory response, followed by b), a refractory 
(desensitization) and reversible state if the dose employed is small. However, if 
capsaicin is administered in large doses c), an irreversible desensitization due to 
neurotoxicity occurs [13]. Neonatal animals are particulariy susceptible to the neurotoxic 
effects of capsaicin [11,13]. Capsaicin and DHC share the same pungent and neurotoxic 
properties [11]. 
Sheep have been proposed as a suitable model to study allergen-induced 
asthma in human beings [15,16] and tachykinins have a crucial influence on the 
response to allergen by sensitized sheep [16]. The density and location of mast cells in 
the lower respiratory tract of sheep [15] may influence the intensity of this response. In 
this report we studied the neurotoxic effects of DHC in neonatal lambs by assessing the 
area covered by SP fibers in the nasal mucosa; additionally, we determined the density 
of mast cells In the upper and lower respiratory tract and the histamine content of the 
lung. Our results provide fundamentals for the understanding of basic conditions that 
may influence the defense mechanisms dependent on the mast cell-substance P nerve 
axis in the respiratory tract. 
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2. Material and Methods 
2.1. Animals and treatment protocols 
Eighteen lambs, of either sex and mixed breed, 3 to 5 days old, were obtained from Iowa 
State University, Laboratory Animal Resources. The animals were maintained in 
isolation rooms in accordance with the methods approved by the American Association 
of Laboratory Animal Care. The experimental protocol was previously approved by the 
Iowa State University Animal Care Review Committee. The animals weighed 5.30 ± 0.38 
kg (mean ± SEM) on the day of arrival. After 24 h, these animals were randomly 
assigned to two large groups; one group receiving DHC while the other received the 
vehicle without the compound. Subsequently, these groups were subdivided in 
accordance to the time of sacrifice at 3, 9, and 21 days after DHC or vehicle 
administration. This arrangement gave six groups, each one with three animals (see 
below the experimental design in section 2.6). 
DHC (8-methyl-N-vanillylnonanamide: Sigma Chemical Co., St. Louis, MO) was 
dissolved in a 25 mg/ml solution composed of 80% pyrogen free saline (NaCI 0.9%), 
10% Tween 20 (Sigma Chemical Co., St. Louis, Ml) and 10% ethanol. The compound 
was initially mixed in ethanol to obtain its complete dissolution. The animals received 
DHC at a dose of 50 mg/kg or the vehicle alone, by several subcutaneous injections into 
the nape of the neck. Prior to DHC injections, the animals were deeply sedated with 
xylazine (0.6 mg/kg, intramusculariy). The animals received banamine (10 mg/lamb, 
intramuscularly) 45 min before DHC/vehicle injection to ameliorate the pain resulting 
from administration of the pungent compound. Subsequently, the animals also received 
isoproterenol (0.2 (xg/kg, intramuscularly) to counteract the bronchoconstriction induced 
by DHC. 
2.2. Euthanasia and collection of samples 
Animals were euthanized with an overdose of sodium pentobarbital. The samples 
collected including nasal septum, ventral concha, trachea (cranial part), trachea (caudal 
part), and lung. The lung corresponded to two parts, one including intrapulmonary 
bronchi and the other a distal part of the lung. The samples were collected In duplicate 
and were fixed by immersion in 10 % neutral buffered fomrialin (48 h at room 
temperature) or in Camoy's fixative (18 h at 4°C). The samples were processed 
routinely, embedded in paraffin wax, and sectioned at 4 |im. Additionally, similar 
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samples were collected in cryo-vials (Nunc CryoTube, Nalge Nunc Int. Naperville, IL) 
and maintained at -SCC for future histamine detemninations. 
2.3. Low pH toluidine blue and immunohistochemistry procedures 
Tissues fixed in Carnoy's fixative were stained with low pH toluidine blue in order to 
recognize mast cells. The procedure yielded a pale bluish background and mast cells 
appeared deeply blue. This procedure has been employed to stain mast cells in the 
human lung [17]. 
The immunohistochemistry procedure for substance P was a modification from 
those methods described by Sakamoto et al. [18] and Sonea, et al. [19,20], in the brain 
and the lung, respectively. Substance P immunoreactlvity was determined in slides from 
formalin-fixed tissues employing a rabbit anti-substance P primary antibody (Peninsula 
Laboratories, Inc., San Carlos, CA). Briefly, the slides were heated in an oven for 30 min 
at 58°C and deparaffinized in xylene and a succession of graded alcohols. 
Subsequently, they were subjected to peroxidase blocking by immersing the slides In a 
solution of 0.9% H2O2 during 40 min. After several rinses in buffer (Wash Buffer, 
BioGenex, San Ramon, CA) the slides were incubated at room temperature during 20 
min with a solution containing 10% normal goat serum and 3% bovine serum albumin 
(Elisa-grade BSA, Sigma Chemical Co., St. Louis MO) dissolved in buffer. Then, the 
slides were incubated in an humidified and sealed chamber at 4°C during 72 h with the 
primary antibody diluted 1:10,000 in antibody diluent (Common Antibody Diluent, 
BioGenex, San Ramon, CA). The slides were rinsed several times and subjected to 
incubation at room temperature for one hour with the secondary antibody (affinity-
purified biotin-labeled. Goat anti-Rabbit IgG (H+L), Kirkegaard & Perry Laboratories, 
Gaithersburg, MD) diluted 1 ;200. After several rinses, the peroxidase-conjugated 
streptavidin reagent (Super Sensitive HRP, BioGenex, San Ramon, CA) was added 
(undiluted) for incubation at room temperature for one hour. Finally, slides were rinsed 
again and a metal enhanced DAB substrate that utilizes cobalt chloride and nickel 
chloride (ImmunePure® metal Enhanced DAB Substrate Kit, Pierce Chemical Co., 
Rockford, IL) was added for 15 min. The slides were then rinsed thoroughly in ultrapure 
water and, without counterstaining, they were dehydrated through alcohols, cleared in 
xylene, and coverslipped in Permount (Sigma Chemical Co.). The positive reaction at 
the site of antigen-antibody-peroxidase complex produced a dark brown/black 
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precipitate. Negative controls in which the primary antibody was omitted gave no 
immunostaining. Small intestine sections (ileum) from sheep were used as positive 
controls because these areas contain myenteric and submucosal plexuses with large 
numbers of immunoreactive nerve fibers and nerve cells bodies. Because we did not 
characterize the peptide reacting with our primary antibody and a cross-reaction with 
other related tachykinines (neurokinin A and neurokinin B) was possible, the tenn 
substance P-like immunoreactivity (SP-Li immunoreactivity) is used hereafter. 
2.4. Quantitation of mast cells and image analysis for substance P-
immunohistochemistry 
For quantification of mast cells, slides containing two sections of each area of respiratory 
tract already mentioned were assessed by light microscopy. The slides were randomly 
assigned and mast cells density was determined by counting the numbers of mast cells 
present in 50 randomly chosen fields at 400 x magnification. The area provided is 
equivalent to 5.9 mm^ [21]. The values obtained per lamb corresponded to counting the 
50 fields in each one of the sections and then averaging these values. The values were 
expressed in mm^. 
Only the nasal septum, which is rich in SP-fibers, was used for image analysis of 
SP-Li immunoreactive fibers. The sections were examined with a Zeiss Axioskop fitted 
with Neofiur objectives, a 100-W light source, and a Sony DXC-3000A camera. The 
images were captured with Visilog Softwere (Noesis, St. Laurent, Quebec, Canada) on 
an SGI 02 workstation (Silicon Graphics, Inc., Mountain View, CA). Subsequently, 
images were edited on a Micron workstation with Photoshop (Adobe, Mountain View, 
CA). 
For image analysis, the slides were randomly assigned without knowledge of the 
treatments. Each slide contained two sections of the nasal septum from each one of the 
animals. Ten fields randomly chosen from each one of the slides were captured. The 
magnification employed gave the same area (84266.12 ^m^). The images containing 
SP-Li immunorective nerve fibers, including positive reaction encountered in nerve 
bundles, were edited by tracing exclusively the positive immunostained areas, procuring 
a close approximation to the shape. Subsequently, the images were thresholded for 
analysis. The values obtained from the ten fields were added; thereby, the value for 
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each animal was a total of the areas with SP-Li immunoreactivity (expressed in fam^) per 
0.84 mm^. The values were adjusted proportionally to be expressed at 1 mm^. 
2.5. Histamine determination 
The content of histamine in the lung was measured employing an enzyme immunoassay 
(Histamine Enzyme Immunoassay Kit, Immunotech, Marseille, France). The lower limit 
of detection of this assay is 0.5 nM and the specificity is 100% to acylated histamine. 
Briefly, 15 mg of tissue were placed in a plastic tube containing 150|ai of 0.2 N HCIO4. 
The tissue was homogenized and centrifuged at 10,000 x g for 5 min at 4°C. 
Supernatant was collected and added to an equal volume of 1M, pH 9.25 of K2B4O7. 
Subsequently, the sample was centrifuged again and the supernatant collected. Then 
the samples were acylated as suggested by the manufacturer. A microplate with 
antibody-coated wells were filled with the tissues' supernatants and incubated for 2 h at 
4°C with shaking at 350 rpm. The wells were rinsed and the substrate was added for 
incubation during 30 min at room temperature. The reaction was stopped and the plate 
was read in an automated spectrophotometer at 410 nm. The histamine content was 
expressed in ng of histamine/g of wet weight of lung parenchyma. 
2.6. Statistical analysis 
Mast cell counts obtained from the different parts of the respiratory tract, as well as SP-
Li immunoreactive fibers in nasal septum, and histamine content in the lung, were 
analyzed among the groups employing a completely random design with 2x3 factorial 
arrangement. The model was yijk=^+ai+fij*(afi)ij+sijk. In this model a had two levels, 
vehicle- and DHC-treatments; /? had three levels, 3, 9, and 21 days of euthanasia after 
treatments; (ap) represents the interaction, and E the en-or [22]. After demonstrating 
statistical significance with a minimum of P < 0.05, the procedure was extended to 
recognize the simple effects'contribution in interactions {ap) by an Ftest and/or the 
major contributions in levels of time p employing contrasts Q = 2"ciYi- [22]. The 
experimental design Is presented In Table 1. Additionally, a model of linear regression, 
Yi -a +pxi * d, was employed to analyze the areas covered by SP-LI immunoreactive 
fibers in nasal septa (^dependent variable; the means of each group) of DHC- and 
vehicle-treated lambs and their probable relationship with days of euthanasia {X 
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independent variable) [22], The same procedure was carried out with mast cells in the 
lung (^dependent variable; the means of each groups). 
3. Results 
3.1. DHC administration 
Immediately after DHC administration the lambs reacted with apnea lapses followed by 
rapid shallow breathing. The animals also exhibited swallowing movements. At this time 
those animals with the most severe reactions were administered an extra doses of 
xylazine and banamine. After this initial period that lasted approximately 20 min, the 
animals showed decreasing respiratory abnomfialities and the swallowing movements 
were more common. Four hours later the lambs were conscious, most of them were in 
sternal position and few were already recuperated. By 6 h all animals appeared normal 
and had regained their appetites. In the following days the DHC-treated lambs appeared 
less active than controls but ate similarly to controls. No skin lesions were detected in 
the site of injection or in other tissues during post mortem examination. 
3.2. Substance P-Li immunoreactive fibers depletion in nasal septum 
After reviewing all of the slides processed for substance P-immunohistochemistry from 
different parts of the respiratory tract, it was determined that only those of the nasal 
septum had enough density of fibers to permit a quantitative comparison between the 
groups. The SP-Li immunoreactive nerve fibers in the nasal septa of DHC-treated lambs 
were decreased approximately 85% in comparison with those treated with vehicle (P< 
0.005). In vehicle-treated animals the fibers were mostly distributed around submucosal 
glands and blood vessels (Figs. 1A and C). Also in many places, small fibers reached 
the epithelial surface. In DHC-treated animals the fibers were scarce and those 
remaining appear shortened (Figs. 16 and D). Although there was a tendency of 
reduced area of SP-Li immunoreactive fibers in vehicle-treated animals with age; the 
factorial experiment did not detect any significant contribution of time (P> 0.05) (Fig. 2). 
However, the linear regression model demonstrated a negative linear relationship 
between the area covered by the fibers and the time of euthanasia (P< 0.025; R^= 0.99), 
confirming a decrease in SP-Li fibers with time. Conversely, in DHC-treated animals, 
these SP-Li fibers remain depleted with no evidence of linear relationship (P> 0.05) (Fig. 
2). 
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As was indicated, only the nasal septa had sufficient density of fibers to be 
compared by statistical procedures. Nonetheless, in vehicle treated animals SP-Li 
immunoreactive fibers were recognized in the different levels of the respiratory tract, 
particularly in the airways, and similarly associated to submucosal glands and blood 
vessels. In DHC treated animals, SP-Li immunoreactive fibers were extremely rare. 
3.3. Mast cells density in the respiratory tract 
The density of mast cells in the respiratory tract was modified by OHC treatment. Those 
animals receiving DHC had more mast cells in the respiratory tract than the controls 
treated with vehicle. The difference was statistically significant (P< 0.05 or higher 
significance levels) for all parts of the respiratory tract studied (nasal septum, cranial and 
caudal trachea, intrapulmonary bronchus, and lung; Figs. 3, 5,6, 7, and 8, respectively), 
except for ventral conchae (P> 0.05) (Fig. 4). Similarly, the influence of time in increased 
numbers of mast cells was statistically significant, particularly at 21 days (P< 0.05 or 
higher significance levels), except for trachea (both cranial and caudal) which had values 
close to significance (P= 0.084 and P= 0.077, respectively). There was no interaction 
between treatments and time (P> 0.05), except in nasal septum in which this interaction 
showed significance (P< 0.05). Two representative fields of mast cells in the lung in 
vehicle- and DHC-treated animals are presented in Fig. 1E and F. 
After detennining that mast cells in the lung had a marked tendency to increase 
throughout time, a model of linear regression was applied to both vehicle- and DHC-
treated animals. The model was adequate to demonstrate a positive linear regression 
relationship between number of mast cells and time of euthanasia in vehicle treated 
animals (P< 0.05; R^= 0.99). However, the same procedure showed a poor linear 
relationship between these variables (P= 0.079) in DHC-treated animals. 
In all sections of the respiratory tract, mast cells were particularly abundant in the lamina 
propria and submucosa of the ainvays. Occasionally, mast cells were located subjacent 
to the epithelial layer. The lung had the highest numbers of mast cells and these were 
similariy abundant in the intrapulmonary ain^/ays as well as in the alveolar septa. Mast 
cells were also abundant in the adventitia of blood vessels, in the pleura, and in the 
interiobular septa. 
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3.3. Histamine content in the lung 
After determining that mast cells were most numerous in the lung, the histamine 
determinations were carried out exclusively in this tissue. The content of histamine in the 
lung was not modified by DHC treatment. Although DHC treated animals had discrete 
and minimal increases of histamine at 9 and 21 days, respectively; these were not 
significant (P> 0.05). Similariy, the higher amount of histamine showed by both DHC and 
vehicle treated animals by day 21 was not significantly different from groups sacrificed at 
3 and 9 days (P> 0.05) (Fig. 9). 
4. Discussion 
In the present study we recognized SP-Li immunoreactive fibers in the entire respiratory 
tract, both upper (nasal septum, ventral concha, cranial and caudal trachea) and lower 
(intrapulmonary bronchi, bronchioles, alveoli). However, only the nasal septum had a 
high enough density of SP-Li fibers suitable for a parametric comparison. A previous 
study in hamsters, guinea-pigs, rats, cats, and dogs, also demonstrated that SP fibers 
are sparse in the alveolar walls [23]. In the lung of horses, SP-Li fibers were more 
numerous In the large airways of the lung close to the hilus than caudal lobes and 
peripheral parenchyma [19,20]. In the trachea of sheep, SP fibers were present 
occasionally [24] whereas in the nasal mucosa of pig they were observed forming a 
dense networi< [4]. More recently, in a model of respiratory tract viral infection in rats, it 
was demonstrated that respiratory syncytial virus enhances the neurogenic inflammation 
in the upper and lower ainA/ays by increasing the SP (NK-1) receptor on target cells [25]. 
However, the capsaicin-induced neurogenic inflammation was significant only in the 
extrapulmonary ainA/ays of virus-infected rats, whereas the intrapulmonary ainA/ays 
responded to exogenous SP administration [25]. It has been suggested that capsaicin-
sensitive C-fibers are more numerous in proximal airways and progressively decreases 
toward the distal parts [25]. During postnatal maturation of respiratory tract SP-fibers 
apparently decrease, i.e. it has been observed that SP-Li fibers were more numerous in 
neonatal foals than in adult horses [20]. We recognized a negative linear relationship 
between the area occupied by SP-Li immunoreactive fibers and time of euthanasia in 
vehicle-treated animals, which confimis the previous observation In horses. 
It is widely accepted that capsaicin administered to neonatal animals in large 
doses, pennanently depletes SP from primary afferent sensory C-fibers [11,13,26]. This 
56 
neurotoxic effect also occurs with DHC [11]. SP depletion occurs because of a massive 
degeneration of these fibers due to destruction of the corresponding peptidergic neurons 
[12,26]. It has been estimated that neonatal capsaicin treatment in rats provokes 
degeneration of up to 90% of unmyelinated primary afferent fibers [26]. Similarly, Carobi 
[27] found that this treatment destroys 70% of small and medium-sized afferent neurons 
in the vagal ganglia. In the present study, the area occupied by SP-Li immunoreactive 
fibers in the mucosa and submucosa of the nasal septum in lambs markedly decreased 
(85%) in DHC-treated animals in comparison with vehicle- treated controls. This data is 
in agreement with the previous work in rats [26], Similarly, our data in vehicle-treated 
lambs is compatible with the values expressed in length of SP immunoreactive fibers in 
the nasal mucosa of normal rats [28]. Nonetheless, due to their naturally tortuous pattern 
with many varicosities, we suggest that data expressed in ^m^ is more accurate to 
describe, in parametric terms, the density of SP-Li immunoreactive fibers. Although we 
did not compare DHC treatment in older sheep, the results suggest that SP-Li fibers 
depletion is long lasting and probably life-long as has been demonstrated in rats. 
Lambs treated with DHC had an augmented density of mast cells in all areas of 
the respiratory tract studied, except ventral concha. However, mast cell homing and/or 
proliferation do not appear to be drastically modified by treatment with DHC, because 
density of mast cells show similar patterns in both DHC- and vehicle-treated animals. 
Mast cells are scarce in the newborn rat [29] and have a progressive pattern of lung 
homing and/or proliferation that reach the peak at 18 weeks in mice [30]. This is in 
agreement with our results that show a major influence of time in the number of mast 
cells. In the lung, which had the highest numbers of mast cells, the density of mast ceils 
throughout time occurs with a positive linear pattern. Although this linear relationship 
was decreased in DHC-treated lambs; a linear relationship remains evident. Taking in 
account values of mast cells in the lung of three 4 month-old sheep employed in a 
different experiment (mean 134.26 ± 7.84 SEM), and comparing them with a predicted 
value from our calculated regression in vehicle-treated animals, provide compatible 
results. In sheep, mast cell numbers most likely continuously increase up to adult age 
because Chen, et al. [15] reported values of 210 mast cells/mm^ in the lung. On the 
other hand, except for nasal septa, in which an interaction between time and DHC 
treatment was detected, the two factors behave independently. This means that DHC 
treatment was a single effect that provoked increased numbers of mast cells but does 
57 
not alter their pattern of homing and/or proliferation in the respiratory tract; in both, 
vehicle- and DHC-treated animals, progressive increases of mast cell density is 
influenced by time. It is important to mention that conventional mice have increased 
numbers of mast ceils in comparison to specific pathogen-free and genn-free animals in 
the nasal mucosa [31]. Thereby, increases of mast cells throughout time may reflect a 
time-related exposition to antigens that naturally challenge mucosal surfaces such as the 
respiratory tract. In these sites mast cells function as orchestrators of the acute 
Inflammatory response [1]. 
When capsaicin is administered to adult rats and pigs, there is no modification In 
the number of mast cells [5]. However, neonatal rats treated with capsaicin have 
Increased numbers of mast cells In the lung [6,32]. The latter Is In agreement with our 
results. It has been suggested that one or more factors released from afferent C-fibers 
might exert a selective negative control on proliferation of mast cells that Is lost after 
denervation [33]. Alternatively, after capsaicin treatment, the massive release of 
neuropeptides (SP, neurokinin A, somatostatin, and calcitonin-gene-related peptide 
among others) which colocalize in C-fibers [12] along with neurotrophins such as nerve 
growth factor, may promote mast cell proliferation [33]. Additionally, cytokines released 
from degranulated mast cells (tumor necrosis factor-a, Interleukins 3, 4, 5, 8, and 13 
among others) may also promote their own proliferation [33]. Nerve growth factor could 
be present in high amounts during this particular situation because mast cells are also 
important extraneural producers of this neurotrophin [34]. Nerve growth factor 
administered to neonatal rats induces an Increase in mast cell density in peripheral 
tissues [34]. In the present study, the Increased availability of these factors was probably 
a single event that occurred after DHC treatment and could explain the initial augment In 
the numbers of mast cells. Paradoxically, the values of histamine In the lung of lambs 
were similar In DHC and vehicle treated animals, despite the increased number of mast 
cells detected. Compatible findings have been reported by Dimitriadou, et al. [6] who 
encountered similar levels of mast cell proteases and histamine synthesis in capsaicin-
treated and control rats, although capsaicin treated rats had higher numbers of mast 
cells. This was interpreted as an individual mast cell reduction in proteases and 
histamine synthesis due to capsaicin denervation, and suggests that mast cells require 
intact nerve fibers in order to express complete activity [6]. 
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Mast cells arrive to the tissues in an immature state and require several factors to 
complete their maturation in situ [36], After OHC treatment, the absence or imbalance in 
these trophic factors could have influenced both, mast cells and their tissue 
environment, impeding an appropriate histamine (and probably other mast cell products) 
synthesis as normally occurs in mature mast cells. Conversely, high number of mast 
cells in certain conditions such as parasitic infections in rats, are accompanied by an 
increase in mast cell-nerve contacts [35] and an augmented response to 
neuroinflammatory inducers [36]. Under these conditions, the increased numbers of 
mast cells correlate with high amounts of histamine and proteases simply because the 
nerve-mast cell axis is completely functional [6]. It has been proposed that, under 
physiological conditions, mast cells activity is subjected to a positive control by 
neuropeptides which favors histamine release. Subsequently, a negative control is 
exerted by histamine acting on H3 receptors on sensory nerve endings, inhibiting release 
of neuropeptides [6,8-10]. This regulatory negative-feedback loop was cleariy reduced in 
DHC treated animals. 
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Table 1 
Experimental Design 
Arrangement of Groups in a 2 x 3 Factorial Experiment 
Group 1 Group 3 Group 5 
Vehicle (a1) (a1b1) (a1b2) (a1b3) 
n=3 n=3 n=3 
Factor A 
Treatments 
Group 2 Group 4 Group 6 
DHC (a2) (a2b1) (a2b2) (a2b3) 
n=3 n=3 n=3 
3 days (b1) 9 days(b2) 21 days(b3) 
Factor B Time of Euthanasia 
Fig. 1. Representative fields of nasal septum (A-D) and lung (E, F) from vehicle- and 
DHC- treated lambs. A, distribution of SP-Li immunoreactive fibers in close association 
to submucosal glands in vehicle-treated lamb, killed at 3 days. B, similar area in a DHC-
treated lamb killed at the same period showing few shortened fibers that remained after 
treatment. C, SP-Li immunoreactive fibers around a small artery in a vehicle-treated 
lamb killed at 3 days. 0, similar area in a DHC-treated lamb killed at the same period 
showing no immunoreactivity. Nasal septum, x 400, immunohistochemistry. E, 
distribution of mast cells in the lung of a vehicle-treated lamb killed at 21 days. F, a 
comparable area in a DHC-treated lamb killed at the same period showing an increased 
number of mast cells. Lung, x 160, low pH toluidine blue. 
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3days(b1) 9days(b2) 21 days (b3) 
Fig. 2. Substance P-Li immunoreactive fibers in nasal septum. Values correspond 
to the area covered by SP-Li immunoreactive fibers in ^m^/mm^ and are expressed 
as mean ± SEM for each group. DHC (a2) treatment is different from vehicle (a1) 
(P< 0.005). There is no influence of factor B (P> 0.05). There is a negative linear 
regression relationship between the area covered by the fibers and time of euthanasia 
(P< 0.025; R^= 0.99). There is no evidence of linear relationship in DHC treated 
animals (P> 0.05). 
66 
E 
E 
*5 
u 
IS 
40 ^ 
38 j 
36 j 
34 -j 
32 -
30 . 
28 1 
26 ^ 
24 * 
22  ^
20 j 
18 i 
16 i 
14 : 
12 ; 
10 • 
8 -
6 J 
4 i 
2 j 
0 ^ 
vehicle 
DHC 
3 9 21 
Days of Euthanasia After Treatment 
Vehicle (a1) G1 6.43 ±1.49 
DHC(a2r G2 9.06 ±2.54 
3days(b1) 
G3 9.06 ± 0.75 
G4 7.96 ± 0.25 
9 days(b2) 
G5 11.04 ±1.33 
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Fig. 3. Mast cells in nasal septum. Values correspond to numbers of mast cells/mm^ 
and are expressed as mean ± SEM for each group. DHC (a2) treatment is different 
from vehicle (a1) (P< 0.05). Day 21 (b3) is different from days 3 and 9 (P< 0.005). 
Factors A and B interact (P< 0.05); the simple effects contributing to this interaction 
correspond to DHC (a2) and day 21 (b3). 
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Fig. 4. Mast cells in ventral concha. Values con-espond to numbers of mast cells/ 
mm^ and are expressed as mean ± SEM for each group. Factor A, treatments, have 
no influence (P> 0.05). Day 21 (b3) results different from days 3 and 9 (P< 0.005). 
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Fig. 5. Mast cells in trachea (cranial). Values correspond to numbers of mast 
cells/mm^ and are expressed as mean ± SEM for each group. DHC treatment (a2) 
is different from vehicle (a1) (P< 0.005). There is no influence of factor B 
(P> 0.05). 
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Fig. 6. Mast cells in trachea (caudal). Values correspond to numbers of mast cells/ 
mm^ and are expressed as mean ± SEM for each group. DHC treatment (a2) is 
different from vehicle (a1) (P< 0.005). Factor B has no influence (P> 0.05). 
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Fig. 7. Mast cells in intrapulmonary bronchus. Values correspond to numbers 
of mast cells/mm^ and are expressed as mean ± SEM for each group. DHC (a2) 
treatment is different from vehicle (a1) (p< 0.005). Day 21 (b3) results different 
from days 3 and 9 (P< 0.005). 
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Fig. 8. Mast cells in lung. Values correspond to numbers of mast cells/mm^ and 
are expressed as mean ± SEM for each group. DHC (a2) resulted different from 
vehicle (a1) (P< 0.01). Day 21 (b3) is different from days 3 and 9 {P< 0.005). 
There is a direct linear regression relationship between number of mast cells and 
time of euthanasia in vehicle treated animals (P< 0.05; R^= 0.99). DHC treated 
animals have a poor linear relationship between these variables (P< 0.1). 
72 
200 ^ i \ \ 
i DDHC : I 
180 ^ 
160 
I  •  
r ^ ;  i l  T M  I  
100 ^ 
'iMl 
3 9 21 
Days of Euthanasia After Treatment 
Vehicle (a1) G1 116.20 ± 12.17 G3 91.31 ±24.60 G5 156.02 ± 17.29 
DHC(a2) G2 90.53 ±36.52 G4 128.19 ±39.17 G6 159.27 ± 17.14 
3 days(b1) 9 days(b2) 21 days(b3) 
Fig. 9. Histamine content in the lung. Values correspond to histamine in ng/g 
wet lung and are expressed as mean ± SEM for each group. There is no influence 
of factor A (P> 0.05) or factor B (P> 0.05). 
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CHAPTER 5. MAST CELL QUANTIFICATION AND SUBSTANCE P-LIKE 
IMMUNOREACTIVITY DURING THE INITIATION AND PROGRESSION OF LUNG 
LESIONS IN OVINE MANNHEIMIA (PASTEURELLA) HAEMOLYTICA PNEUMONIA 
A paper submitted for publication (3/8/00) to Veterinary Pathology 
R. Ramfrez-Romero, K. A. Brogden, J. M. Gallup, I. M. Sonea AND M. R. Ackermann 
Abstract. In order to determine the numbers of stained mast cells (MCs) and extent of 
substance P (SP) immunoreactivity during initiation and progression of Manntieimia 
{Pasteurella) haemolytica pneumonia, eighteen lambs were inoculated intrabronchially 
with M. haemolytica or saline and lung tissue was collected at 1, 15, and 45 days post 
inoculation (n=3, each group). Additionally, the left (non-inoculated) contralateral lungs in 
bacteria-inoculated animals were collected as controls. At 1 day after bacterial 
inoculation the lungs had typical M. haemolytica lesions. Stainable MCs were absent in 
these areas, and histamine content was reduced. Leukocytes infiltrating some of these 
affected areas, most likely macrophages, were strongly immunoreactive for SP, 
suggesting an important extraneural contribution to the inflammatory process. At 15 
days, MCs remain scarce at sites where lung damage persisted, i.e. pyogranulomatous 
foci, but become hyperplastic in areas of interstitial damage. Substance P 
immunoreactivity indicated that not only an extrinsic sensory innervation, but also an 
intrinsic contribution of pulmonary ganglion neurons, sustains the inflammatory 
response. By 45 days the fibrosing changes become more defined such as pleural 
fibrosis, fibrosing alveolitis, and bronchiolitis obliterans. These lungs had increased 
numbers of MCs; however, the histamine content did not correspond to this increased 
population. Substance P immunoreactivity appeared only in nerves and was mild. The 
diminished SP immunoreactivity during the chronic stages of lung damage may 
correspond to a lack of protective effects elicited by SP, including regulation of 
inflammatory response and promotion of epithelial repair. This work demonstrates that 
during the acute stage of pneumonic pasteurellosis (PP) the sites with the most severe 
lung lesions have reduced numbers of stained MCs and extraneural SP 
immunoreactivity. Whereas in chronic stages, the areas of epithelial hyperplasia have 
increased numbers of MCs and SP fibers immunoreactivity is decreased. 
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Mast cells (MCs) are necessary for both the acquired and innate defense 
mechanisms.^®'^ ^ In the lung, MCs orchestrate both the inflammatory and immune 
responses.^ Mast cells produce an array of vasoactive compounds and cytokines 
necessary to mount the acute phase of inflammatory response; additionally, MCs are 
able to internalize bacteria and present antigens to immune cells.^ During the acute 
inflammatory response in the lung, MCs are required for neutrophil infiltration and 
bacterial clearence.^^ However, MCs also contain proteases and growth factors that 
make them an important component in chronic inflammatory responses such as chronic 
lung diseases. 
The unmyelinated C-fibers are an important component of the sensory 
innen/ation in the lung/'* ®'' These fibers are in close apposition to MCs^®, and through 
the neuropeptide substance P (SP) acting on its specific receptor (neurokinin-1 receptor 
[NK-1R]) located on the surface of MCs, exert a functional connection to induce MC 
activation.^^ Conversely, MC-tryptase can exert a positive feedback by acting as a signal 
molecule, cleaving and activating a proteinase-activated receptor (PAR)-2 located at the 
surface of sensory nerves, and inducing release of sensory neuropeptides, including 
Sp51 
Substance P is the tachykinin responsible for neurogenic inflammation in the lung 
and other tissues/ Although the main source of SP are unmyelinated C-fibers, this 
neuropeptide is also normally expressed by small numbers of thin myelinated A5 afferent 
fibers/ However, during persistent inflammation, additional Ap fibers, which normally do 
not express SP, can acquire the capacity to express the neuropeptide/® More recently, 
an important contribution of ain/vay ganglion neurons that produce SP and express NK-
1R during immune-mediated neurogenic inflammation in the lung has been recognized/^ 
In addition, there are other extraneural sources of SP such as alveolar macrophages 
and neutrophils, particulariy in lipopolysaccharide-inflammed lungs/^ 
The pathogenesis of the severe lung damage that characterizes pneumonic 
pasteurellosis (PP) is still poorly understood and most of the studies have emphasized in 
the pathogenic mechanisms operating during the acute stage of this pneumonic 
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syndrome.^^ However, the lung lesions remaining during the sub-acute and chronic 
stages, which are responsible for the decreased productivity of affected animals, have 
received little attention. 
The objective of this work was to determine the extent to which the development 
of chronic PP affects the density of MCs and SP production, both of which are key 
elements in chronic lung diseases of man. 
Materials and Methods 
Experimental animals 
Eighteen sheep, of both sexes and mixed breed, three months old, were 
obtained from Iowa State University, Laboratory Animal Resources. The animals were 
maintained in isolation rooms in accordance with the procedures approved by the 
American Association of Laboratory Animal Care. The Iowa State University Animal 
Care Review Committee approved this protocol previously. After 24 h, the animals were 
randomly assigned to two large groups; one group receiving Mannheimia {Pasteurella) 
haemolytica while the other received saline. Subsequently, these large groups were 
subdivided in accordance to the time of sacrifice at 1,15, and 45 days after inoculation. 
This arrangement gave six groups, each one with three animals (Table 1). 
Inoculation 
Mannheimia haemolytica (strain 82-25; originally recovered from a natural case 
of PP in sheep) was grown in tryptose broth medium for 3 h at 37''C and then suspended 
in pyrogen- f ree sa l ine (PFS;  Baxter  hel thcare Corp. ,  Deer f ie ld ,  I I I )  to  achieve 1x10® 
colony-forming units (CFU)/ml.® The bacteria-inoculated animals received 5 ml of the 
bacterial inoculum into the right cranial lobe bronchus whereas the controls received the 
same volume of PFS. The inoculation was carried out employing a fiber-optic 
bronchoscopy as previously described.^-^ 
Euthanasia and coliection of lung samples 
Animals were euthanized with an intravenous overdose of sodium pentobarbital. 
Samples were collected from the site of inoculum deposition in the right lung; 
additionally, from those animals that received the bacterial inoculum, the equivalent site 
in the non-inoculated (left) lung, was also collected. Samples were obtained in duplicate 
to be fixed by immersion in 10% neutral buffered fonnalin (48 h at room temperature) or 
Camoy's fixative (18 h at 4° C). Furthermore, small pieces of lung tissue from the same 
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areas were collected in cryo-vials (Nunc CryoTube, Nalge Nunc Int. Naperville, IL) and 
maintained at -80° C for histamine determinations and bacteriological studies. 
Histopathology, mast cell staining and quantitation 
Tissues fixed in Carnoy's fixative were processed routinely, embedded in paraffin 
wax, and sectioned at 4 ^m. Serial sections were stained with H & E, Mallory's 
trichrome, and low pH toluidine blue. The special stains were employed for recognition of 
connective fibrous tissue and MCs, respectively. Low pH toluidine blue yielded a pale 
bluish background where MCs appeared deeply blue. This procedure has been used to 
stain MCs in the human lung.^^ 
For quantification of MCs, slides containing two sections of the right lung were 
assessed by light microscopy. The slides were randomly assigned and MCs density was 
detemfiined by counting the numbers of MCs present in 50 randomly chosen fields at 
400X magnification. The area provided is equivalent to 5.9 mm^.^° The values obtained 
per sheep corresponded to counting the 50 fields in each one of the sections and then 
averaging these values. A similar procedure was carried out in the left, non-inoculated 
lungs of the animals that received the bacterial inoculum. The values were expressed as 
MCs/mm^. 
Histamine detemfilnation 
The content of histamine in the lung was measured employing an enzyme 
immunoassay (Histamine Enzyme Immunoassay Kit, Immunotech, Marseille, France). 
The lower limit of detection of this assay is 0.5 nM and the specificity is 100% to acylated 
histamine. Briefly, 50 mg of tissue were placed in a plastic tube containing 500|il of 0.2 N 
HCIO4. The tissue was homogenized and centrifuged at 10,000 x g for 5 min at 4°C. 
Supernatant was collected and added to an equal volume of 1M, pH 9.25 of K2B4O7. 
Subsequently, the sample was centrifuged again and the supernatant collected. Then 
the samples were acylated as suggested by the manufacturer. A microplate with 
antibody-coated wells were filled with the tissues' supernatants and incubated for 2 h at 
4°C with shaking at 350 rpm. The wells were rinsed and the substrate was added for 
incubation during 30 min at room temperature. The reaction was stopped and the plate 
was read in an automated spectrophotometer at 410 nm. The histamine content was 
expressed in ng of histamine/g of wet weight of lung tissue. 
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Substance P immunohistochemistry 
Tissues fixed in neutral buffered formalin were also processed routinely and 
serial sections were stained with H & E or left unstained to can7 out the substance P 
immunohistochemical procedure. The immunohistochemical procedure was a 
modification from those methods described by Sakamoto et a//® and Sonea et in 
the brain and the lung, respectively. Substance P immunoreactivity was determined 
employing a rabbit anti-SP primary antibody (Peninsula Laboratories, Inc., San Carlos, 
CA). Briefly, the slides were heated in an oven for 30 min at 58° C and deparaffinized in 
xylene and a succession of graded alcohols. Subsequently, they were subjected to 
peroxidase blocking by immersing the slides in a solution of 0.9% H2O2 during 40 min. 
After several rinses in buffer (Wash Buffer, BioGenex, San Ramon, CA) the slides were 
incubated at room temperature during 20 min with a solution containing 10% normal 
goat serum and 3% bovine serum albumin (Elisa-grade BSA, Sigma Chemical Co., St. 
Louis MO) dissolved in buffer. Then, the slides were incubated in a humidified and 
sealed chamber at 4°C during 96 h with the primary antibody diluted 1:10,000 in 
antibody diluent (Common Antibody Diluent, BioGenex, San Ramon, CA). The slides 
were rinsed several times and subjected to incubation at room temperature for one hour 
with the secondary antibody (affinity-purified biotin-iabeled, Goat anti-Rabbit IgG (H+L), 
Kirkegaard & Perry Laboratories, Gaithersburg, MD) diluted 1:200. After several rinses, 
the peroxidase-conjugated streptavidin reagent (Super Sensitive HRP, BioGenex, San 
Ramon, CA) was added (undiluted) for incubation at room temperature for one hour. 
Finally, slides were rinsed again and a metal enhanced DAB substrate that utilizes 
cobalt chloride and nickel chloride (ImmunePure© metal Enhanced DAB Substrate Kit, 
Pierce Chemical Co., Rockford, IL) was added for 15 min. The slides were then rinsed 
thoroughly in ultrapure water and, without counterstaining, they were dehydrated through 
alcohols, cleared in xylene, and coverslipped in Pemiount (Sigma Chemical Co.). The 
positive reaction at the site of antigen-antibody-peroxidase complex produced a dark 
brown/black precipitate. Negative controls in which the primary antibody was normal 
rabbit serum gave no immunostaining. Small intestine sections (ileum) from sheep were 
used as positive controls because these areas contain myenteric and submucosal 
plexuses with large numbers of immunoreactive nerve fibers and nerve cells bodies. 
Because we did not characterize the peptide reacting with our primary antibody and a 
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cross-reaction with other related tachykinines was possible, the term SP-like (SP-Li) 
immunoreactivity is used hereafter. 
Additional studies 
Small pieces of the right lung were collected in cryo-embedding medium (OCT 
compound, Miles Inc., Elkhart, IN) and stored at -80° C. This material was subsequently 
sectioned in a cryostat for an immunohistochemical procedure to detect Mycoplasma 
ovipneumoniae by indirect immunofluorescence employing a rabbit anti M. 
ovipneumoniae antiserum. The procedure is a modified protocol from the technique 
described by Amanfu, et al.^ 
Samples of blood were taken from each animal the day after arrival and the day 
scheduled for euthanasia after inoculation. Passive hemagglutination titers to M. 
haemolytica lipopolysaccharide were assessed from these samples.^" 
Samples maintained at -80° C were used for serial dilution and plated on sheep 
blood agar (TSA/sheep blood agar; Remel, Lenexa, KS) to detemriine the number of 
CPU per mg of lung tissue. The identification of the bacterial isolates was carried out by 
conventional bacteriological procedures. 
Statistical Analysis 
The numbers of MCs as well as histamine determinations were subjected to 
statistical comparisons. Each group receiving the bacterial challenge were compared 
with the conresponding control at the same time period employing a Student's t test, 
assuming independent samples and equal variances.^" Additionally, in the bacterial 
challenged groups, the non-inoculated (left) lungs were compared against the inoculated 
(right) ones with a paired Student's t test.®° 
Results 
Pathology 
Gross lesions. Animals killed at 1 day post-inoculation with M. haemolytica had 
severe lesions of hemorrhage and lung consolidation in the right lung; particulariy at the 
ventral area of the caudal part of the cranial lobe. The lesions had a diameter of 8 cm 
approximately. One animal also had mild lesions on the dorsal area of the cranial part of 
the cranial lobe and on the pulmonary hilium. In two animals the pleural surface covering 
the affected areas had a coarse appearance with delicate strands of fibrin. 
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The post-mortem exam of animals that received the bacterial inoculum and killed 
15 days after revealed marked fibrous adhesions between parietal and visceral pleura 
on the surface of the caudal part of the cranial lobe. The lungs showed a depressed 
surface with grayish areas of discoloration and a rubbery to firm texture. One animal also 
showed fibrous adhesions between pleura and pericardium. Sections of the affected 
lungs contained abscesses with extensive areas of necrosis in two animals. 
At 45 days after M. haemolytica inoculum, the lesions were more variable; the 
lungs of two animals showed Irregular depressed areas on the surface with grayish 
discoloration located mainly at the caudal part of the cranial lobe but also extending 
toward the dorsal part and to the hilium. These areas were mbbery in texture and were 
alternating with areas of normal appearance and texture in the lung. The pleura covering 
the affected and adjacent areas appeared thickened. In one animal there were mari^ ed 
fibrous adhesions between the parietal and visceral pleura with extensive areas of 
pleural thickness. The lung was markedly rubbery in texture. No exudate was recognized 
in these lesions. 
The macroscopic lesion in controls were practically absent except in two cases in 
which discrete areas of grayish discoloration were present at the cranial part of the 
cranial lobe. The non-inoculated (left) lungs were absent of lesions in all of the animals. 
Microscopic lesions. The lungs of animals killed 1 day post-inoculation with M. 
haemolytica had extensive areas of proteinaceous edema, hemorrhage, and necrosis 
typical of PP. In the most affected areas the alveolar architecture was mari<edly distorted 
due to luminal accumulation of a sero-fibrinous exudate and leukocytes. In many areas 
there were swiris of necrotic neutrophils and macrophages occupying the alveolar 
lumina (Fig. 1A). Bronchioles were also plugged with neutrophils and cell debris. Pleural 
surface contained fibrin and was also infiltrated by neutrophils. Alveolar capillaries and 
some small blood vessels had fibrin thrombosis and adjacent edema. In two cases were 
recognized small clusters of coccobaclllary bacteria associated with the alveolar lesions. 
The pattern of affected areas showed mostly a lobular distribution where interlobular 
septa appeared distended due to edema, fibrin and hemorhage. One animal in this 
group had a mild hyperplasia of peribronchiolar lymphoid tissue In some areas. The low 
pH toluidine blue stain demonstrated a conspicuous absence of MCs in those areas 
showing the most severe damage (Fig. 1B). Trichrome stain showed no major changes 
in the pattern of connective tissue distribution. 
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By 15 days after bacterial Inoculation the histopathological appearance of the 
lungs were more variable. The lung of two animals had large foci of pyogranulomatous 
reactions composed of lymphocytes, plasma cells and large (sometime binucleated) 
foamy macrophages (Fig. 2A), and limited by fibrous tissue (Fig. 2B). In some of these 
pyogranulomatous foci remnants of limiting bronchial/bronchiolar epithelium was still 
discernible. Furthermore, few bacterial coccobacilli colonies were recognized in some of 
these lesions. Mast cells were practically absent in the core of the pyogranulomatous 
foci and scarce in the margins. The connective fibrous tissue in some interiobular septa 
and pleura was extremely increased to the point of encroaching on some collapsed 
lobules (Fig. 3). In addition there was a marked proliferation of large and cuboidal 
alveolar epithelial cells mainly at terminal bronquioles and adjacent alveoli. These areas 
were commonly intervened by delicate strands of fibrous connective tissue with 
numerous lymphocytes and macrophages intermingled (Fig. 4). The lamina propia and 
submucosa of large bronchi were markedly infiltrated by lymphocytes and plasma cells. 
Additionally, these animals showed some areas with a mild hyperplasia of 
peribronchiolar lymphoid tissue. The lesions in the other animal included in this group 
were more interstitial in character. The lesions were less severe and characterized by 
alveolar and bronchiolar epithelialization with abundant macrophages exudating into the 
alveolar spaces (Fig. 5A). The toluidine blue special stain demonstrated surprisingly an 
increase in the number of MCs (Fig. 58). Pleura and interiobular spaces also showed a 
marked fibroplasia. 
Animals killed at 45 days after bacterial inoculation had a variable degree of 
chronic changes. One animal had discrete areas of interstitial pneumonia with epithelial 
proliferation in alveoli and bronchioles. These areas alternated with others that had 
alveolar atelectasis or emphysema and still others with no significant changes at all. 
Nonetheless the pleura and interiobular septae were thickened due to fibrous tissue. 
Similariy, some interiobular small blood vessels had medial hypertrophy and adventitial 
proliferation of fibrous tissue (Fig. 6). This animal also had a mild hyperplasia of 
peribronchiolar lymphoid tissue. The other two animals also had interstitial lesions but 
the proliferation of epithelium, particulariy at bronchioles, was always accompanied by a 
mari<ed infiltration of lymphocytes and plasma cells. Additionally, these small airways, 
which appeared segmented and tortuous, sometimes contain fibrous connective tissue 
fonning organized masses inside the lumen (bronchiolitis fibrosa obliterans; Fig. 7). 
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These fibrosing changes extend into the sunrounding parenchyma. The pleura and 
interlobular septa were markedly expanded by a dense connective tissue that supported 
well developed blood vessels and nerves (Fig. 8A). Mast cells were numerous in these 
areas of fibrosis; however, they were even more numerous in those adjacent areas of 
parenchyma showing the interstitial changes, and around the hyperplastic bronchioles 
(Fig. 8B). Macrophages were the dominant cell population in the alveolar lumen with 
occasional clusters of neutrophils and cell debris occluding bronchioles and adjacent 
alveoli. Some arteries adjacent to bronchioles had marked hypertrophy of the media that 
occludes their lumen and also perivascular lymphocytes and plasma cells infiltrates. 
These cells also infiltrated the lamina propria and submucosa of large bronchi. 
Most of the lung of controls lacked lesions. However, three had mild hyperplasia 
of peribronchiolar lymphoid tissue with no other significant changes. Similariy, four of the 
non-inoculated (left) lungs of animals that received the bacterial inoculum had the same 
discrete lymphoproliferative changes. The density of MCs in controls as well as the 
noninoculated lungs of animals that received the bacterial inoculum was typical for 
lambs of this age. The density and distribution of pulmonary connective fibrous tissue 
was also typical for ovine lung. 
Mast cell quantitation 
The number of MCs was altered in bacterial inoculated animals. Those animals 
killed at 1 day after bacterial inoculation had decreased numbers of pulmonary MCs in 
their right (inoculated) lungs in comparison with the conresponding controls (Student's t 
test; P< 0.01). Similarly, the inoculated (right) lungs had lower numbers of MCs than the 
non-inoculated (left) lungs in the bacteria-inoculated group (Student's t test; P< 0.05). In 
the case of animals killed at 15 days after bacterial inoculation, the number of MCs were 
no different from controls killed at the same time period (Student's t test; P> 0.05), 
neither the non-inoculated lungs had different numbers than the inoculated ones 
(Student's t test; P> 0.05). It is important to mention that in this bacteria-inoculated group 
there was a high variability in the numbers of pulmonary MCs. Whereas one animal with 
interstitial pneumonia had higher numbers of MCs, the others with pyogranulomatous 
lesions had lower numbers. Finally, the bacteria-inoculated animals sacrificed at 45 days 
after inoculation had higher numbers of MCs in their right lungs than the conresponding 
controls (Student's t test; P< 0.01) as well as their non-inoculated contralateral lungs 
(Student's t test; P< 0.05). These results are presented in Fig. 9. 
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Histamine determinations 
Bacteria-inoculated animals killed at 1 day had reduced values of histamine in 
their inoculated lungs than controls (Student's t test; P< 0.001) as well as lower than 
their noninoculated contralateral lungs (Student's t test; P< 0.01). However, neither the 
bacteria-inoculated groups euthanized at 15 days nor those killed at 45 days had 
significant differences in these comparisons (Student's t test; P> 0.05). Nonetheless, at 
45 days, the values of histamine in the bacteria-inoculated lungs were higher and close 
to significance when compared with both controls (Student's; P= 0.055) and their 
contralaterals (Student's; P= 0.052). Figure 10 presents these results. 
Substance P-like immunoreactivity 
At day 1 after bacterial inoculation the SP-Li immunoreactivity appeared mostly in 
leukocytes surounding or enmeshed in the areas of most severe damage (Fig. 11). 
These cells reacted strongly, although not as much as nen/e fibers. Serial sections 
stained with H&E showed that most of the cells were macrophages. The 
immunoreactivity of nerve fibers associated with the aioA/ays and blood vessels 
appeared decreased, particulariy in areas of most severe damage. 
By day 15 after bacterial inoculation the SP-Li immunoreactivity was mostly 
confined to nerve fibers. However, the large macrophages surrounding the areas of 
necrosis iri the pyogranulomatous foci had a mild immunoreactivity. Many of the nerve 
fibers immunoreacted strongly and appeared thicker in areas in which they normally 
were faint in controls. For example, thicker SP-Li immunoreactive fibers were seen in 
some distorted tenninal bronchioles (Fig. 12), around small blood vessels (Fig. 13) and 
in alveolar walls. Furthermore, some small bronchioles had also irregularly thickened 
immunoreactive fibers (Fig. 14), and occasionally enlarged myelinated fiber bundles that 
were immunoreactive (Fig. 15). Some large peribronchial ganglion neurons located in 
the submucosa of few bronchi had an intense immunoreaction (Fig. 16). All of these 
changes were obsen/ed in areas in which the pulmonary damage appeared with 
interstitial pattern. The SP-Li immunoreactivity occurs more scant in areas of extreme 
parenchymal fibrosis and was rare in areas of pleural and interlobular fibrosis. 
At 45 days after bacterial inoculation the SP-Li immunoreactivity was confined to 
nerve fibers in a very similar way as in the previous group. However, in some areas of 
interstitial-fibrosing damage the fibers appeared less numerous and had a variable 
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degree of immunostaining; few appeared strongly immunolabelled but most of them 
showed mild Immunoreactivity. 
The lung of controls and the conresponding non-inoculated lungs in bacteria-
inoculated animals had a pattern of immunoreactivity similar to that described in horses 
(Sonea, et al., 1994 a,b). The immunoreaction was present in small nerve fibers that had 
the typical varicosities of unmyelinated C-fibers in the lamina propria and submucosa of 
bronchi and in the adventitia of adjacent blood vessels. Bundles of myelinated fibers also 
had several enmeshed immunoreactive fibers. However, the immunolabelling was not 
present in peribronchial neuronal cell bodies. Similariy, small unmyelinated fibers and 
some myelinated ones also had immunoreactivity around small bronchioles and small 
blood vessels. The immunoreactivity was extremely rare in tenninal bronchioles and 
alveoli and when it was recognized showed very tiny nerve fibers. Nonetheless, the 
immunoreactive nerve fibers showed a more consistently pattern of distribution and 
stronger immunoreaction than bacteria-inoculated lungs. 
Additional studies 
Mycoplasma ovipneumoniae immunfluorescence. Some of the lungs of control 
animals as well as bacteria-inoculated sheep had a positive reaction to M. 
ovipneumoniae. In groups killed at 1 day after inoculation one control was weak positive 
and two bacteria-inoculated animals were weak positive and positive, respectively. One 
animal in the bacteria-inoculated group killed at 15 days was positive whereas two 
controls were positive. The groups sacrificed at 45 days after inoculation had one 
positive animal each. There was no massive accumulation of antigen in any of the 
positive sections, and the positive reaction was not related to infiltrating or exudating 
cells. 
Serology. All of the animals showed positive titers to M. haemolytica LPS at 
arrival. Titers oscillated between 4 to 32 with an average mean and SEM of 18.88±2.66. 
After challenge the control groups maintained their titers whereas the bacteria-inoculated 
groups changed. At 1 day after bacterial inoculation the animals showed a decrease in 
the titer; 18.66±7.05 at arrival and 12±4 at time of euthanasia. At 15 days the titer 
increased; 18.66±7.05 at arrival and 48±16 at time of euthanasia. And at 45 days the 
titer showed a discrete increase; 45.33±18.66 at anival and 52±8.10 at time of 
euthanasia. 
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Bacteriology. M. haemolytica was recovered from bacteria-inoculated animals at 
1 day and 15 days after challenge but not at 45 days. The lungs of animals killed at 1 
day had 80 and 400 CFU/mg of lung tissue. Only samples from two animals were 
available for this study in this group. Bacteria-inoculated animals killed at 45 days had 
40, 3500, and 580 CFU/mg lung tissue. The first value correspond to the animal with an 
interstitial pattern of pneumonic lesions whereas the other values conrespond to animals 
with pyogranulomatous abscesses. The bacteriological studies from saline-inoculated 
controls lacked M. haemolytica colonies. 
Discussion 
We have been working with a model of PP in ruminants employing Mannheimia 
{Pasteurella) haemolytica inoculated intrabronchially by fiber-optic bronchoscopy. This 
procedure reproduces typical lesions located mainly in the site of inoculum deposition.^^ 
Moreover, as was observed in the present work, the procedure results in a lesion 
confined to the inoculated lung and no involvement of the contralateral lung. This 
characteristic permits the bacteria-inoculated animals to develop a focal lesion of PP that 
evolve as probably occurs in natural infections. The time points for euthanasia were 
chosen as representative of the acute, sub-acute, and chronic stages of the pneumonic 
lesion. 
The acute lesions observed at 1 day after bacterial inoculation were 
characterized by severe serofibrinous alveolitis and bronchopneumonia, extensive areas 
of coagulative necrosis with presence of swiris of oat cells obliterating the alveolar 
spaces, and thrombosis of capillaries and small blood vessels. These microscopic 
changes have been considered the hallmaric of the acute stage of PP.^ '^^ ^ Recently, it 
has been proposed that these changes may occur by two different pathological 
mechanisms that can act alone or in combination, depending on the circumstances; 
these are the Arthus and the Shwartzman reactions.'^ ^ Both mechanisms could, 
eventually, activate the complement system allowing the participation of MCs, 
neutrophils, and macrophages, with release of many pro-inflammatory compounds, 
including cytokines such as tumor necrosis factor (TNF)-a, interieukin (IL)-1, and IL-8. 
The final result is an exacerbated host inflammatory response.'*^ Apparently, the 
bacterial lipopolysaccharide is a more important inducer of lung inflammation and tissue 
damage than the leukotoxin/^"*^ The decrease in the serum titers against M. 
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haemolytica lipopolysaccharide in bacteria-inoculated animals killed at this time point 
could represent a consumption of specific antibodies during the acute inflammatory 
response. On the other hand, the bacteria counts in the lungs of these animals appear 
low considering the severe lung damage observed, supporting the idea of an 
exacerbated host inflammatory response/^ 
Preliminary work in this laboratory demonstrated that at 6 h after intrabronchial 
inoculation of M. haemolytica in neonatal calves, those areas in the lung with severe 
damage have decreased numbers of MCs and MCs that were still recognizable 
appeared degranulated/^ In the present study in sheep, MCs were conspicuously 
absent at areas of acute lung damage at 1 day after bacterial inoculation. The overall 
number of MCs in these areas was statistically reduced in comparison with saline-
inoculated controls and non-inoculated contralateral lungs in bacteria-inoculated 
animals. This supports Cheville's suggestion that during acute inflammation 
recognizable MCs decrease due to their degranulation.^^ Mast cells are considered the 
orchestators of the acute inflammatory response in the lung due to their content of 
preformed pro-inflammatory compounds, particulariy TNF-a.^^ Moreover, it has been 
reported that MCs recovered from cattle infected with M. haemolytica release increased 
amount of histamine in vitro,^ and that bacterial leukotoxin and lipopolysaccharide both 
cause an increase in spontaneous release of histamine from Isolated bovine lung 
parenchyma.^^ The amount of histamine in the bacteria-inoculated lungs was statistically 
lower than the values in saline-inoculated controls and the non-inoculated contralateral 
lungs of bacteria-inoculated animals, confimning the previous reports. 
It was an unexpected and striking finding that leukocytes infiltrating those areas 
of severe lung damage had SP-Li immunoreactivity. Conversely, the nerve fibers 
associated with ainways and blood vessels located in areas of severe damage reacted 
only moderately probably due to an early depletion of neuropeptides. In rats it has been 
demonstrated that alveolar macrophages normally express the preprotachykinin-l gene 
mRNA which encodes SP and neurokinin A; however, during lung inflammation induced 
by lipopolysaccharide, the preprotachykinin gene-l mRNA is expressed two to fourfold 
and SP can be recognized by immunocytochemistry.^^ Thus, it is logical to assume that 
in our study the induction of pulmonary inflammation by M. haemolytica exerted a similar 
stimulus that resulted in recognition of SP-Li immunoreactivity in infiltrating leukocytes. 
Although serial sections stained with H&E demonstrated that alveolar macrophages 
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were the main cell type Immunoreacting, neutrophils could also be reacting because 
these cells also express the preprotachykinin gene-l mRNA and immunoreact to SP in 
lipopolysaccharide-inoculated lungs of rats.^° Moreover, eosinophils also synthesize, 
store, and release substance P.^ Therefore, in addition to sensory C-fibers, 
inflammatory cells infiltrating the lung might be an important source of tachykinins, as 
has been suggested by Killingsworth et al.^^ This extraneural production of SP may 
contribute to an inflammatory imbalance that favors severe lung damage. On the other 
hand, it is possible that the moderate reaction observed in nerve fibers could be related 
to degranulated MCs because trypsin-like enzymes contained in their granules can 
activate sensory nerves through PAR2, inducing relase of sensory neuropeptides.^^ 
Dungworth'^  and Lopez^® coincide in mentioning that in animals surviving an 
acute episode of PP a complete resolution is rare and the process commonly includes 
sequelae such as bronchiolitis obliterans, bronchiectasia, pulmonary sequestra and 
abcesses, pulmonary fibrosis, and chronic pleuritis with fibrous pleural adhesions. In the 
present study ail of these changes were found in animals killed at 15 and 45 days after 
bacterial inoculation. However, in all of them, the interstitial component characterized by 
alveolar and bronchiolar epithelialization was an important component. Although some of 
the lungs included in these groups (as well as the groups killed at 1 day) reacted 
positively to M. ovipneumoniae by immunohistochemistry, the reaction did not show a 
massive accumulation of antigen and was neither associated with interstitial cellularity or 
exudation. This was interpreted as a short-term infection; possibly secondary to the 
bronchoscopy procedure during bacterial or saline intrabronchial deposition. Additionally, 
the histological changes, particularly the peribronchial and perivascular lymphoid 
hyperplasia, considered characteristic of Mycoplasma spp. infection,were barely seen 
in these animals. Therefore, the interstitial changes are most likely the result of M. 
haemolytica infection. This assumption is reinforced with the lack of significant 
histological changes in saline-inoculated controls and non-inoculated contralateral lungs 
in bacteria-inoculated animals. 
At 15 days after bacterial infection, the animals had two patterns of sequelae, 
one with a prominent interstitial change characterized by alveolar and bronchiolar 
epithelialization, accompanied by large numbers of MCs and high amount of histamine. 
Conversely, the others had pyogranulomatous foci arising from bronchiectactic airways 
that predominated over the interstitial pattern, with lower numbers of MCs and also lower 
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amount of histamine. This wide variability resulted in no statistical difference when these 
values were compared with the corresponding saline-inoculated controls neither the 
contralateral non-inoculated lungs in the bacteria-inoculated animals. Sorden and 
Castleman^^ have demonstrated in a model of viral bronchiolitis in rats infected with 
Sendai virus, that a significant increase in MCs occurs only after day 14 post-infection, 
which is in agreement with our findings in one of the animals. However, our observations 
indicate that whereas the inflammatory reaction remains active and associated with 
tissue damage, such as the pycgranulomatous foci accompanied by the highest 
numbers of CPU, MCs remain absent in these areas. Nonetheless, the extensive areas 
of fibrosing alveolitis and the fibroplastic changes in pleura and interlobular spaces were 
consistently seen at this time point. 
Because the pyogranulomatous foci were delineated by well-differentiated fibrous 
tissue and MCs were scarce in these areas, we can assume that in certain 
circumstances fibrosis occurs first and independently from MCs. This observation has 
been previously reported in the lungs of patients that survived acute stages of adult 
respiratory distress syndrome. In these cases fibrosis appears before MCs 
hyperplasia.^^ Additionally, rats genetically deficient in MCs were still capable of 
mounting a fibroplastic lesion in their lungs.^^ Nonetheless, MC infiltration has been 
widely associated with chronic lung disorders in humans.^^ MCs contain proteases and 
growth factors that stimulate lung fibroblast proliferation and synthesis of type I 
collagen,and MCs-fibroblast heterotypic contacts induce MC synthesis of interleukin-
4 which augments fibroblast proliferation." On the other hand, fibroblasts also influence 
MCs due to production of growth factors and particularly stem cell factor, which is 
necessary for MC maturation.^°'^ ^ In our study, at 15 days after bacterial inoculation, MC 
hyperplasia occurred mostly in those areas with interstitial pattern and was always 
accompanied by epithelializing changes and abundant macrophage infiltration in alveolar 
spaces. This pattern of MCs proliferation may represent a functional relationship 
between MCs and epithelial cells to favor epithelial proliferation. Mast cell tryptase is 
also a potent mitogen for epithelial cells in the respiratory tract.^ 
At 15 days after bacterial infection the SP-Li immunoreactivity had a different 
pattern of reaction from the previous group. Here the large macrophages bordering 
those areas with pyogranulomatous reaction had mild immunoreactivity. However, the 
unmyelinated fiber innervating alveoli, terminal bronchioles, small blood vessels and 
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bronchi appeared in'egularly thickened with a moderate to intense immunoreactivity. 
Similarly, large myelinated nerve bundles in bronchioles and bronchi, which in some 
cases appeared enlarged, also contain numerous immunoreactive fragments. The 
presence of some large peribronchial ganglion neurons which were associated with an 
intense immunoreaction, similar to that observed in ganglion cells in the myenteric and 
submucosal plexuses in the small intestine, was a striking feature. When compared with 
the lungs of saline-inoculated controls and with the non-inoculated contralateral lungs of 
bacteria-inoculated sheep, the overall impression for immunoreacting nerve fibers in 
bacteria-inoculated lungs was that of an inregular thickness and enlargement with 
variable intensity of reaction but with a normal pattern of distribution. 
It has been described that during persistent injury in muscles and articular 
ligaments, an increase in SP-immunoreactive nerve fibers occurs."'*^ And in the urinary 
bladder, an organ highly innervated by afferent neurons of C-fiber type located mainly in 
the dorsal root ganglia, chronic inflammation induces their somal hypertrophy.^ In the 
lungs of asthmatic individuals the reports have been contradictory; one study reports an 
increase in SP nerve fibers but others did not confirm this finding.^^ Although in some 
areas of these bacteria-infected lungs we recognized a trend compatible with 
hypertrophy, we cannot assume this criterion because we did not carried out a 
morphometric-quantitative evaluation. In the respiratory tract SP nerve fibers occur with 
highest density at the nasal septum,whereas the lung has few fibers and most of them 
are associated with large ainA/ays.'*^ '*^ For this reason, an accurate analysis of density of 
SP nerve fibers in the lung is probably not feasible. 
We can suggest, however, that in our model at 15 days, there is some degree of 
phenotypic switch as was demonstrated by the unusual SP-Li immunoreactivity of some 
neuronal cell bodies associated with large airways. In general temns, it is widely 
accepted that the majority of SP nerve fibers originating from the lung have their cell 
bodies located in the nodose ganglion of the vagus with lesser numbers in the thoracic 
dorsal root ganglia. '^^  Substance P immunoreactivity has not been recognized in 
ganglionic neurons of the respiratory tract in normal horses.^^-^^-^^ In the cat, however, 
neurons of ain^/ay ganglia express SP immunoreactivity,^^-^^ and explants of ainway walls 
have demonstrated an alteration in phenotypic expression of neuropeptides when 
maintained in culture.^^ Ganglion neurons in the myenteric and submucosal plexuses of 
the gastrointestinal tract are a rich source of tachykinins and this should be expected to 
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occur in the the lung because its embryonic development from the foregut.^^ 
Nonetheless, the presence of SP in intrinsic ainA/ay neurons in the lung has not been 
consistently recognized. The discrepancy could be explained by the fact that ain^/ay 
ganglia contain a heterogeneous population of neurons susceptible to adaptive functions 
under physiological and pathological conditions.^^ 
In certain models of inflammatory pain there is a phenotypic switch in primary 
sensory neurons which normally do not express SP but become committed during 
persistent inflammatory injury.^^^^ Apparently, this transcriptional and posttranslational 
plasticity is induced mainly by nerve growth factor,^® " and mast cells are an important 
source of nerve growth factor/ Thus, as has been demonstrated in models of 
inflammatory pain,®" the expression of SP-Li immunoreactivity in some ganglion 
neurons recognized here, may represent a novel expression of SP to sustain the 
inflammatory reaction. P^rez Fontan and coworkers^® have demonstrated recently that 
syngeneic lung grafts, which lack (extrinsic) peptidergic sensory innervation, still produce 
SP and NK-1R by intrinsic ainway neurons. Furthemiore, these transplanted lungs were 
able to mount an immune-mediated pulmonary inflammatory response that 
corresponded to SP production and was attenuated by NK-1R antagonists.^® 
By 45 days after bacterial inoculation the fibrotic pattern of alveolitis and 
bronchiolitis become more pronounced as did the fibrosing changes in pleura and 
pleural adhesions. None of the animals sacrificed at this time point had significant 
exudative changes although macrophages were still abundant in the alveolar spaces in 
some areas. At this time point, the alveolar and bronchiolar changes were defined more 
precisely as fibrosing alveolitis and bronchiolitis fibrosa obliterans, respectively, although 
these changes were present to a lesser degree at 15 days after bacterial challenge. The 
increased numbers of pulmonary MCs were maintained and represented by a higher 
amount of histamine in comparison with the saline-inoculated controls and the non-
inoculated contralateral lungs of bacterial-inoculated sheep. Nonetheless, this trend of 
histamine increase was not statistically significant. Maturation of MCs is a process that 
occurs mediated by many environmental conditions in the tissue,^ and during conditions 
of proliferation MCs mature asynchronously and their granules contain variable amounts 
of histamine.^^ Thus, it is possible that during the chronic stages of lung inflammatory 
response the higher number of MCs included a large population of immature cells with 
lower amount of histamine. Recognition of immature MCs by toluidine blue is possible 
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because the expression of proteoglycan matrix in their granules occurred first and 
regulates the content of histamine, proteases and other granule components.^^ '^* 
The SP-Li immunoreactivity in bacteria-inoculated animals at 45 days after 
challenge occurred with a decreased pattern of distribution in comparison with bacteria-
inoculated animals killed at 15 days. Also, the intensity of the immunostaining was 
variable, but mostly decreased. Moreover, in none of the lungs was there any positive 
immunolabelling of peribronchial neuronal bodies. This group also lacked any 
extraneural SP-Li immunoreactivity. According to bacteriological studies no viable M. 
haemolytica were recovered from these lungs indicating that, in absence of the 
infectious agent, the chronic lesions persist. In animal models of chronic bronchitis, it 
has been demonstrated that, in contrast to being detrimental, SP nerve fibers exert a 
beneficial adaptive response during chronic injury favoring a regulatory action on the 
inflammatory response. The lowered pattern of SP nerve fibers distribution as well as 
the low immunoreactlon observed in these bacteria-inoculated lungs may reflect a 
deficient function of C-flbers and therefore a tendency to maintain or increase the lung 
injury. 
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Table 1 
Experimental Arrangement 
Time of Euthanasia 
1 day 15 days 45aays 
Treatments 
M.haemolytica n=3 n=3 n=3 
Saline n=3 n=3 n=3 
Mannheimia haemolytica (strain 82-25) was grown in tryptose broth medium for 3 
h at 37*'C and then suspended in pyrogen-free saline to achieve 1x10° CFU/ml. 
The bacteria-inoculated animals received 5 ml of the bacterial inoculum into the 
right cranial lobe bronchus by fiber-optic bronchoscopy whereas the controls 
received the same volume of PFS. Additionally, the left (non-inoculated) lungs of 
the bacteria-inoculated animals were also employed as contralateral negative 
controls. 
Fig. 1. Lung of bacteria-inoculated animal killed at 1 day. The alveolar spaces contain 
serofibrinous exudate and are partially-filled with macrophages and neutrophils. In some 
areas the cellular exudate forms typical swiris of oat cells (A). H&E stain. Bar=40^m. 
There is one mast cell partially degranulated in this field that corresponds to a serial 
section of the same area presented previously (B). Low pH toluidine blue stain. 
Bar=40^m. 
Fig. 2. Lung of bacteria-inoculated animal killed at 15 days. There are many large and 
vacuolated macrophages, some of them binucleated, in the margins of a necrotic area in 
a pyogranulomatous abscess (A). H&E stain. Bar=40^m. Serial section of the same area 
to demonstrate that the pyogranulomatous abscesses were limited by fibrous connective 
tissue (B). Mallory's trichrome stain. Bar=60^m. 
Fig. 3. Lung of bacteria-inoculated animal killed at 15 days. The proliferated but 
unorganized fibrous connective tissue in pleura and interlobular septum encroaches a 
collapsed pulmonary lobule. Mallory's trichrome. Mallory's trichrome stain. Bar=60^m. 
Fig. 4. Lung of bacteria-inoculated animal killed at 15 days. There is proliferation of 
epithelial cells at terminal bronchioles and alveoli. The parenchyma is intervened by 
strands of connective fibrous tissue. There are also many infiltrating leukocytes, mostly 
lymphocytes and macrophages with few clusters of neutrophils. Mallory's trichrome. 
Bar=^m. 

Fig. 5. Lung of bacteria-inoculated animal killed at 15 days. There is a thickened 
appearance of alveolar septa due to epithelial proliferation. Numerous macrophages are 
occupying the alveolar spaces (A). H&E stain. Bar=40|am. The corresponding serial 
section of this area demonstrate a large number of mast cells, some of them 
hypertrophied (B). Low pH toluidine blue. Bar=:40^m. 
Fig. 6. Lung of bacteria-inoculated animal killed at 45 days. Two small arteries in an 
interlobular septum are accentuated by medial hypertrophy and fibrous connective tissue 
proliferating in the adventltia. Mallory's trichrome. Bar=40^m. 
Fig, 7. Lung of bacteria-inoculated animal killed at 45 days. There are several 
proliferated and tortuous bronchioles with hyperplastic epithelium partially-filled with 
exudate at different stages of organization. The lesion was classified as bronchiolitis 
fibrosa obliterans. Mallory's trichrome. Bar=40^m. 
Fig. 8. Lung of bacteria-inoculated animal killed at 45 days. The pleura is thickened due 
to a massive proliferation of dense fibrous connective tissue. The adjacent parenchyma 
is atelectatic and the bronchioles appear proliferated and tortuous (A). Mallory's 
trichrome. Bar=60^m. The corresponding serial section shows the distribution of the 
proliferated mast cells. Most of these cells reside in lung parenchyma or proliferate 
around small bronchioles whereas few of them infiltrate the fibrous connective tissue at 
pleura (B). Low pH toluidine blue. Bar=60^m. 
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Fig. 9. Mast cell density in the lung. Values are expressed as mean ± SEM. 
At 1 day, bacteria-inoculated animals had significantly lower number of MCs 
in their lungs than saline-inoculated control animals (**P< 0.01). Also, the 
bacteria-inoculated (right) lungs had lower numbers of mast cells than the 
non-inoculated (left) lungs in bacteria-inoculated animals (*P< 0.05). At 45 days 
the lungs of bacteria-inoculated animals had higher numbers of MCs than 
saline-inoculated controls (**P<0.01) as well as their non-inoculated left lungs 
CP<0.05) 
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Fig. 10. Histamine content in the lung. Values are expressed as mean ± SEM. 
At 1 day, bacteria-inoculated animals had significantly lower amount of histamine 
In their lungs than saline-inoculated control animals (**P<0.001). Also, the 
bacteria-inoculated (right) lungs had lower amount of histamine than the non-
inoculated (left) lungs in bacteria-inoculated animals (**P<0.01). 
Fig. 11. Lung of bacteria-inoculated animal killed at 1 day. There are numerous 
immunoreactive leukocytes, probably macrophages, infiltrating an area with extensive 
damage. Substance-P immunolabelling (no counterstain). Bar=40^m. 
Fig. 12. Lung of bacteria-inoculated animal killed at 15 days. There is a cluster of 
immunoreactive nerve fibers located in a bronchiolo-alveolar junction in an area of 
interstitial damage. Substance-P immunolabelling (no counterstain). Bar=20^m. 
Fig. 13. Lung of bacteria-inoculated animal killed at 15 days. There is a thickened 
immunoreactive nerve fiber adjacent to a small blood vessel in an area of interstitial 
damage. Substance-P immunolabelling (no counterstain). Bar=20^m. 
Fig. 14. Lung of bacteria-inoculated animal killed at 15 days. There is a fragmented and 
thickened nerve fiber adjacent to a small bronchiole. Substance-P immunolabelling (no 
counterstain). Bar=20|am. 
Fig. 15. Lung of bacteria-inoculated animal killed at 15 days. There is an enlarged 
bundle of myelinated nerves containing many immunoreactive fragments around a 
bronchiole. Substance-P immunolabelling (no counterstain). Bar=40^m. 
Fig. 16. Lung of bacteria-inoculated animal killed at 15 days. There is a large 
immunoreactive neuron and fragments of myelinated and unmyelinated nerve fibers 
immunoreacting in the submucosa of a large bronchi. Substance-P immunolabelling (no 
counterstain). Bar=20|im. 
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CHAPTER 6. GENERAL CONCLUSIONS 
Mast cells and SP have a relevant role during Initiation and progression of pulmonary 
lesions in PP. The following supports this argument: 
The decreased numbers of stained MCs in sites of severe and acute lung 
damage, typical of PP, is a consistent finding and suggests the participation of MCs 
during early events of lung inflammation, particularly at 6h. Previous administration of a 
sialyl Lewis mimetic (TBC1269) intended to decrease PMN infiltration during the acute 
phase of lung damage has no effect on MC numbers suggesting that MC degranulation 
occurs in spite of selectin inhibition. 
In the second study, a single high dose of OHC administered to neonatal lambs 
depleted peptidergic nerves from SP. This depletion was estimated to be 85% of 
controls, when measured in the nasal septum, which is the site richest in SP nerve 
fibers. In the upper and lower respiratory tract MC density increased progressively with 
age, from 3 to 21 days, but DHC-treated animals had significantly higher numbers of 
MCs in comparison with controls. However, histamine content in the lung was similar. A 
functional association between MCs and SP nerve fibers is suggested. The model is 
suitable for experiments designed to study the inflammatory response in the respiratory 
tract when the neurogenic contribution is diminished. It can be used to critically test the 
effect of SP fibers in PP and other inflammatory diseases of the lung, such as asthma 
and chronic obstructive pulmonary disease. 
In the third study, a diminished number of pulmonary MCs and amount of 
histamine during the acute phase of PP in sheep, was associated with SP 
immunoreactivity in macrophages infiltrating the areas of severe damage, suggesting an 
extraneural contribution of SP during the acute (24h) stage of the lung lesions. At 15 
days, MCs remain scarce at sites where lung damage persisted, i.e. pyogranulomatous 
foci, but become hyperplastic in areas of interstitial damage. At this time point, SP 
immunoreactivity suggested that an extrinsic, but also intrinsic contribution of SP 
immunoreactive nerves sustain the inflammatory response in the lung. By 45 days the 
fibroplastic changes in pleura, interiobular spaces, and interstitium were mari<ed as was 
the presence of bronchiolitis obliterans. These changes were associated with increased 
numbers of MCs; however, elevation in histamine content did not correspond to this 
increment. In areas of severe fibrosis SP immunoreactivity in nen/e fibers was mild 
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suggesting that the absence of SP during the chronic lung damage hinders complete 
tissue repair. This worit suggests that a dysregulation of the MC-SP nerve fiber axis may 
contribute to the epithelial hyperplastic changes. Additional studies are needed to test 
whether this dysregulation prevents the complete resolution of chronic pulmonary 
lesions. 
